[
  {
    "id": "10665-117378",
    "type": "document",
    "title": "[Pilot study of antiretroviral therapy in Djibouti]",
    "author": [
      {
        "family": "Ahmed",
        "given": "A.A."
      },
      {
        "family": "Latoundji",
        "given": "S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/117378",
    "language": "fr",
    "abstract": "A cross-sectional survey was conducted among 112 HIV positive patients who had received antiretroviral therapy for > 3 months to assess the efficacy of treatment [viral load < 400 copies/mL]. The median age at enrolment was 36 years, 90% of patients were at the AIDS stage and median CD4 rate was 118/mm[3]. Patients received a combined treatment of 2 NRTI +1 NNRTI [51%], 3 NRTI [45%] and 2 NRTI+1 PI [4%]. Virological efficacy was seen in 74% of the patients, irrespective of the prescribed protocol and the initial clinical and immunological profile. Mean improvements measured were 20% on the Karnofsky index [KI], 2.1 kg/m[2] in body mass index and 82 cells/mm[3] in CD4. The prevalence of side effects was 84%. The predictors for treatment success were quality of care and KI > 70%"
  },
  {
    "id": "10665-22470",
    "type": "document",
    "title": "Alocución del Director General a la 58ª Asamblea Mundial de la Salud: Ginebra, lunes 16 de mayo de 2005",
    "author": [
      {
        "family": "Asamblea Mundial de la Salud",
        "given": "58"
      },
      {
        "family": "Lee",
        "given": "Jong-Wook"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          12,
          31
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/22470",
    "language": "es"
  },
  {
    "id": "10665-279506",
    "type": "document",
    "title": "Salud digital",
    "author": [
      {
        "family": "Asamblea Mundial de la Salud",
        "given": "71"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/279506",
    "language": "es"
  },
  {
    "id": "10665-83270",
    "type": "document",
    "title": "Tables rondes : enseignements tirés en matière de santé mondiale : Rapport du Secrétariat",
    "author": [
      {
        "family": "Assemblée mondiale de la Santé",
        "given": "52"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1999,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/83270",
    "language": "fr"
  },
  {
    "id": "10665-279507",
    "type": "document",
    "title": "Santé numérique",
    "author": [
      {
        "family": "Assemblée mondiale de la Santé",
        "given": "71"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/279507",
    "language": "fr"
  },
  {
    "id": "10665-37864",
    "type": "book",
    "title": "Progress towards better vaccines : proceedings of a meeting organized by the World Health Organization as part of the Programme for Vaccine Development, held in Bellagio, Italy, by courtesy of the Rockefeller Foundation 16-18 April 1985 / edited by Rosemary Bell and G. Torrigiani",
    "author": [
      {
        "family": "Bell",
        "given": "Rosemary"
      },
      {
        "family": "Torrigiani",
        "given": "G"
      },
      {
        "literal": "World Health Organization"
      },
      {
        "literal": "World Health Organization. Programme for Vaccine Development"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1986,
          12,
          31
        ]
      ]
    },
    "ISBN": "019261567X",
    "URL": "https://iris.who.int/handle/10665/37864"
  },
  {
    "id": "10665-67518",
    "type": "document",
    "title": "Caracteristiques d' activité et de stabilité des vaccines antivarioliques utilisés dans les programmes d' éradication de la variole en Afrique de l' ouest et du centre-ouest / par A. Bernstein et M.Z. Bierly",
    "author": [
      {
        "family": "Bernstein",
        "given": "A"
      },
      {
        "family": "Bierly",
        "given": "M. Z"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1972,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la santé",
    "URL": "https://iris.who.int/handle/10665/67518",
    "language": "Français"
  },
  {
    "id": "10665-44118",
    "type": "book",
    "title": "Casebook on ethical issues in international health research / edited by Richard Cash [... et al]",
    "author": [
      {
        "family": "Cash",
        "given": "Richard"
      },
      {
        "family": "Wikler",
        "given": "Daniel"
      },
      {
        "family": "Saxena",
        "given": "Abha"
      },
      {
        "family": "Capron",
        "given": "Alexander M"
      },
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789290219576 (Arabic)",
    "URL": "https://iris.who.int/handle/10665/44118",
    "language": "en"
  },
  {
    "id": "10665-270347",
    "type": "document",
    "title": "Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals",
    "author": [
      {
        "family": "Charles",
        "given": "Macarthur"
      },
      {
        "family": "Noel",
        "given": "Francine"
      },
      {
        "family": "Leger",
        "given": "Paul"
      },
      {
        "family": "Severe",
        "given": "Patrice"
      },
      {
        "family": "Riviere",
        "given": "Cynthia"
      },
      {
        "family": "Beauharnais",
        "given": "Carole Anne"
      },
      {
        "family": "Miller",
        "given": "Erica"
      },
      {
        "family": "Rutledge",
        "given": "John"
      },
      {
        "family": "Bang",
        "given": "Heejung"
      },
      {
        "family": "Shealey",
        "given": "Wesley"
      },
      {
        "family": "D’Aquila",
        "given": "Richard T"
      },
      {
        "family": "Gulick",
        "given": "Roy M"
      },
      {
        "family": "Johnson",
        "given": "Warren D"
      },
      {
        "family": "Wright",
        "given": "Peter F"
      },
      {
        "family": "Pape",
        "given": "Jean William"
      },
      {
        "family": "Fitzgerald",
        "given": "Daniel W"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          12,
          1
        ]
      ]
    },
    "publisher": "World Health Organization",
    "DOI": "10.2471/BLT.07.050120",
    "URL": "https://iris.who.int/handle/10665/270347",
    "language": "en"
  },
  {
    "id": "10665-266214",
    "type": "document",
    "title": "Vaccins antivarioliques secs",
    "author": [
      {
        "family": "Collier",
        "given": "W. A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1952,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la santé",
    "URL": "https://iris.who.int/handle/10665/266214",
    "language": "fr"
  },
  {
    "id": "10665-3278",
    "type": "document",
    "title": "La vaccination dans le monde : vision et stratégie : rapport du Secrétariat",
    "author": [
      {
        "family": "Conseil exécutif",
        "given": "128"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          12,
          6
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/3278",
    "language": "fr"
  },
  {
    "id": "10665-24399",
    "type": "document",
    "title": "Poliomyélite : intensification de l’Initiative mondiale pour l’éradication de la poliomyélite : rapport du Secrétariat",
    "author": [
      {
        "family": "Conseil exécutif",
        "given": "130"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          4,
          12
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/24399",
    "language": "fr"
  },
  {
    "id": "10665-252004",
    "type": "document",
    "title": "Cartographie du risque de fièvre jaune et vaccination antiamarile recommandée pour les voyageurs : projet de résolution proposé par l’Argentine",
    "author": [
      {
        "family": "Conseil exécutif",
        "given": "136"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/252004",
    "language": "fr"
  },
  {
    "id": "10665-174553",
    "type": "document",
    "title": "Programme d'action pour les médicaments et vaccins essentiels: projet de résolution proposé par le Président du Comité ad hoc et les Rapporteurs",
    "author": [
      {
        "family": "Conseil exécutif",
        "given": "73"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1984,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/174553",
    "language": "fr"
  },
  {
    "id": "10665-179526",
    "type": "document",
    "title": "Stratégie Mondiale de lutte contre le SIDA",
    "author": [
      {
        "family": "Conseil exécutif",
        "given": "89"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1992,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/179526",
    "language": "fr"
  },
  {
    "id": "10665-145614",
    "type": "document",
    "title": "Acta resumida de la primera sesión",
    "author": [
      {
        "family": "Consejo Ejecutivo",
        "given": "22"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1958,
          12,
          31
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/145614",
    "language": "es"
  },
  {
    "id": "10665-266751",
    "type": "document",
    "title": "Possibilités d'amélioration des vaccins anticholériques et méthodes d'évaluation de leur efficacité",
    "author": [
      {
        "family": "Delpy",
        "given": "Louis"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1963,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la santé",
    "URL": "https://iris.who.int/handle/10665/266751",
    "language": "fr"
  },
  {
    "id": "10665-20231",
    "type": "document",
    "title": "Global smallpox vaccine reserve: report by the Secretariat",
    "author": [
      {
        "literal": "Executive Board 115"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/20231",
    "language": "en"
  },
  {
    "id": "10665-327942",
    "type": "document",
    "title": "Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits: draft decision proposed by Secretariat with amendments by Member States",
    "author": [
      {
        "family": "Executive Board",
        "given": "144"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          9,
          25
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/327942",
    "language": "en"
  },
  {
    "id": "10665-172045",
    "type": "document",
    "title": "Joint and cosponsored United Nations programme on HIV/AIDS (draft resolution proposed by Professor Munevver Bertan, Professor J. M. S. Caldeira da Silva, Professor I. Chernozemsky, Dr V. Devo, Mrs P. Herzog, Dr J. Larivière, Dr J. G. S. Makumbi, Professor J. Mbede, Dr E. Nakamura, Dr Ngo Van Hop, Dr B. L. Shrestha and Mr J. F. Varder)",
    "author": [
      {
        "family": "Executive Board",
        "given": "93"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1994,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/172045",
    "language": "en"
  },
  {
    "id": "10665-172302",
    "type": "document",
    "title": "Review and evaluation of specific programmes: global programme for vaccines and immunization",
    "author": [
      {
        "family": "Executive Board",
        "given": "95"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1995,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/172302",
    "language": "en"
  },
  {
    "id": "10665-42988",
    "type": "book",
    "title": "Plan stratégique de l' Initiative mondiale pour l' éradication de la poliomyélite :  2004-2008",
    "author": [
      {
        "literal": "Global Polio Eradication Initiative"
      },
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9242591173",
    "URL": "https://iris.who.int/handle/10665/42988",
    "language": "ru"
  },
  {
    "id": "10665-67839",
    "type": "document",
    "title": "Second meeting of the Global Working Group on TB/HIV : 14-16 June 2002, Durban, South Africa",
    "author": [
      {
        "family": "Global Working Group on TB/HIV. Meeting (2nd : 2002 : Durban",
        "given": "South Africa)"
      },
      {
        "literal": "Stop TB Initiative"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2002,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/67839",
    "language": "en"
  },
  {
    "id": "10665-72254",
    "type": "document",
    "title": "Infections de l' appareil reproducteur : prévalence et facteurs de risques dans une région rurale du Bangladesh / Sarah Hawkes ... [et al.]",
    "author": [
      {
        "family": "Hawkes",
        "given": "Sarah J"
      },
      {
        "family": "Morison",
        "given": "Linda"
      },
      {
        "family": "Chakraborty",
        "given": "Jyotsnamoy"
      },
      {
        "family": "Gausia",
        "given": "Kaniz"
      },
      {
        "family": "Ahmed",
        "given": "Farid"
      },
      {
        "family": "Islam",
        "given": "Shamin Sufia"
      },
      {
        "family": "Alam",
        "given": "Nazmul"
      },
      {
        "family": "Brown",
        "given": "David"
      },
      {
        "family": "Mabey",
        "given": "David"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2002,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/72254",
    "language": "fr"
  },
  {
    "id": "10665-68092",
    "type": "document",
    "title": "Control of smallpox in Delhi Municipal Corporation / by P.H. Jeswani",
    "author": [
      {
        "family": "Jeswani",
        "given": "P. H"
      },
      {
        "literal": "World Health Organization"
      },
      {
        "family": "WHO Inter-Country Seminar on Surveillance in Smallpox Eradication (1972 : New Delhi",
        "given": "India)"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1972,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/68092"
  },
  {
    "id": "10665-271946",
    "type": "document",
    "title": "The importance of assessing self-reported HIV status in bio-behavioural surveys",
    "author": [
      {
        "family": "Johnston",
        "given": "Lisa G"
      },
      {
        "family": "Sabin",
        "given": "Miriam Lewis"
      },
      {
        "family": "Prybylski",
        "given": "Dimitri"
      },
      {
        "family": "Sabin",
        "given": "Keith"
      },
      {
        "family": "McFarland",
        "given": "Willi"
      },
      {
        "family": "Baral",
        "given": "Stefan"
      },
      {
        "family": "Kim",
        "given": "Andrea A"
      },
      {
        "family": "Raymond",
        "given": "H Fisher"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          8,
          1
        ]
      ]
    },
    "publisher": "World Health Organization",
    "DOI": "10.2471/BLT.15.162933",
    "URL": "https://iris.who.int/handle/10665/271946",
    "language": "en"
  },
  {
    "id": "10665-385346",
    "type": "document",
    "title": "Cost-effectiveness of introducing the pneumococcal conjugate vaccine for children under 5 years in the Islamic Republic of Iran",
    "author": [
      {
        "literal": "Khadijeh Ezoji"
      },
      {
        "literal": "Mohsen Yaghoubi"
      },
      {
        "literal": "Marzieh Nojomi"
      },
      {
        "literal": "Sussan Mahmoody"
      },
      {
        "literal": "Seyed Mohsen Zahraie"
      },
      {
        "literal": "Maziar Moradi-Lakeh"
      },
      {
        "literal": "Sedigheh R. Tabatabaei"
      },
      {
        "literal": "Abdollah Karimi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          10,
          29
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for the Eastern Mediterranean",
    "DOI": "https://doi.org/10.26719/emhj.19.039",
    "URL": "https://iris.who.int/handle/10665/385346",
    "language": "en",
    "abstract": "Background:\nPneumococcal disease caused by Streptococcus pneumoniae results in considerable mortality and morbidity. Pneumococcal conjugate vaccines (PCV), such as PCV-13, can prevent invasive pneumococcal disease and avoid disability and death. The cost of introducing PCV-13 in childhood immunization schedules should be assessed against the cost of pneumococcal diseases for each community.\nAims:\nThis study aimed to evaluate the cost–effectiveness of introducing PCV-13 in the national immunization programme for children under 5 years in the Islamic Republic of Iran.\nMethods:\nThe TRIVAC decision support model was used to estimate total costs of introducing PCV-13 and the disability-adjusted life years (DALYs)averted. The main pneumococcal diseases were considered—pneumonia, meningitis, acute otitis media, and non-pneumonia, non-meningitis infections—in terms of hospital admissions, outpatient visits and deaths. Local data were used to estimate costs.\nResults:\nPneumococcal disease is estimated to affect 18 713 211 children under 5 years (519 412 pneumonia, 18 148 116 acute otitis media, 6884 meningitis, and 38 799 non-pneumonia, non-meningitis)in 10 years (2014–2023)without use of the vaccine. Introduction of PCV-13 would prevent 4 900 084 cases of pneumococcal disease (190 849 pneumonia, 4 692 450 acute otitis media, 2529 meningitis, and 14 256 non-pneumonia, non-meningitis). Pneumococcal infection would cause 287 950 hospital admissions and 29 399 deaths; vaccination could avert 105 802 hospital admissions and 9997 deaths. The incremental cost–effectiveness was estimated to be US$ 1890 and US$ 1538 per averted DALY for the government and society respectively.\nConclusion:\nAccording to WHO-recommended thresholds for interpreting cost–effectiveness, introduction of PCV-13 for children under 5 years in the Islamic Republic of Iran would be cost-effective"
  },
  {
    "id": "10665-350543",
    "type": "report",
    "title": "Лечение и уход в связи с ВИЧ/СПИДом в Беларуси: отчет оценочной миссии: январь 2014 г.",
    "author": [
      {
        "family": "Lundgren",
        "given": "Jens D"
      },
      {
        "family": "Raben",
        "given": "Dorthe"
      },
      {
        "family": "Ерамова",
        "given": "Ирина"
      },
      {
        "family": "Ильенкова",
        "given": "Вера"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения. Европейское региональное бюро",
    "URL": "https://iris.who.int/handle/10665/350543",
    "language": "ru",
    "abstract": "Оценка лечения и ухода в связи с ВИЧ/СПИДом выполнена с учетом стратегии или концепции ВОЗ/ЮНЭЙДС «Лечение 2.0», где указаны пять приоритетных областей: оптимизация лекарственных схем, обеспечение доступа к диагностике в местах оказания помощи, снижение стоимости, адаптация систем оказания услуг и мобилизация сообществ или гражданского общества. Для оценки использованы результаты анализа существующих документов и отчетов и страновой миссии, которая состоялась 11-14 ноября 2013 года в гор. Минске и Солигорске, Беларусь. Особое внимание было уделено практике тестирования на ВИЧ, поскольку именно здесь начинается лечение и уход в связи с ВИЧ, а также уязвимым группам и обеспечению доступа к лечению и уходу. Кроме того, была проанализирована устойчивость программ в свете используемых в настоящее время и будущих международных и национальных схем финансирования."
  },
  {
    "id": "10665-268219",
    "type": "document",
    "title": "Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry.",
    "author": [
      {
        "family": "Mayans",
        "given": "M. V."
      },
      {
        "family": "Robertson",
        "given": "S. E."
      },
      {
        "family": "Duclos",
        "given": "P."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2000,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/268219",
    "language": "en"
  },
  {
    "id": "10665-97885",
    "type": "book",
    "title": "The immunological basis for immunization series: module 16: mumps",
    "author": [
      {
        "family": "Mclean",
        "given": "Huong Q"
      },
      {
        "family": "Hickman",
        "given": "C. J"
      },
      {
        "family": "Seward",
        "given": "Jane F"
      },
      {
        "literal": "World Health Organization"
      },
      {
        "literal": "Centers for Disease Control and Prevention (U.S.)"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241500661",
    "URL": "https://iris.who.int/handle/10665/97885",
    "language": "en"
  },
  {
    "id": "10665-264857",
    "type": "document",
    "title": "Étude de l'immunité humorale et cellulaire après vaccination antitétanique chez l'enfant africain malnutri et paludéen : 1 : étude de la réponse en anticorps antitétaniques",
    "author": [
      {
        "family": "Monjour",
        "given": "L."
      },
      {
        "family": "Bourdillon",
        "given": "F."
      },
      {
        "family": "Schlumberger",
        "given": "M."
      },
      {
        "family": "Fayet",
        "given": "M. T."
      },
      {
        "family": "Michon",
        "given": "C."
      },
      {
        "family": "Ballet",
        "given": "J. J."
      },
      {
        "family": "Gouba",
        "given": "E."
      },
      {
        "family": "Gentilini",
        "given": "M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1982,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la santé",
    "URL": "https://iris.who.int/handle/10665/264857",
    "language": "fr"
  },
  {
    "id": "10665-208888",
    "type": "book",
    "title": "Évaluation du lien de causalité pour les manifestations postvaccinales indésirables (MAPI). Manuel d’utilisation de la classification OMS révisée",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          6,
          13
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9789242505337",
    "URL": "https://iris.who.int/handle/10665/208888",
    "language": "fr"
  },
  {
    "id": "10665-329296",
    "type": "report",
    "title": "Le diagnostic du VIH et l’utilisation des ARV chez le nourrisson exposé au virus : mise à jour programmatique",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/329296",
    "language": "fr"
  },
  {
    "id": "10665-331629",
    "type": "report",
    "title": "L’OMS recommande que des approches de dépistage du VIH qui s’appuient sur les réseaux sociaux soient offertes aux populations clés, dans le cadre d’un dispositif de services aux partenaires",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/331629",
    "language": "fr"
  },
  {
    "id": "10665-344250",
    "type": "book",
    "title": "Stratégie mondiale pour la santé numérique 2020-2025",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          8,
          18
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9789240027558 (version électronique)",
    "URL": "https://iris.who.int/handle/10665/344250",
    "language": "fr",
    "abstract": "La Stratégie mondiale pour la santé numérique 2020–2025 fournit un cadre destiné à aider les États Membres à renforcer leurs systèmes de santé grâce à l’adoption et à l’utilisation appropriées des technologies numériques. Élaborée en réponse aux mandats de l’Assemblée mondiale de la Santé et alignée sur les Objectifs de développement durable ainsi que sur les objectifs du « Triple milliard » de l’OMS, cette stratégie présente une vision commune visant à améliorer la santé et le bien-être au moyen de solutions de santé numérique accessibles, abordables, sûres et durables. Elle souligne l’importance d’une gouvernance solide, de l’interopérabilité, de l’utilisation éthique des données, de la protection de la vie privée, du renforcement des capacités des personnels de santé et des investissements dans les infrastructures numériques afin de soutenir les priorités nationales de santé et la couverture sanitaire universelle.\n\nLe document définit quatre objectifs stratégiques : promouvoir la collaboration mondiale et le partage des connaissances ; faire progresser la mise en œuvre des stratégies nationales de santé numérique ; renforcer la gouvernance de la santé numérique aux niveaux mondial, régional et national ; et promouvoir des systèmes de santé centrés sur les personnes grâce aux technologies numériques. Il présente également des principes directeurs, un cadre de mise en œuvre et des mécanismes de suivi destinés à soutenir les pays dans le développement d’écosystèmes numériques interopérables. Une attention particulière est accordée aux obstacles rencontrés par les pays à revenu faible ou intermédiaire et à la nécessité de veiller à ce que la transformation numérique contribue à des systèmes de santé plus équitables, efficaces et résilients."
  },
  {
    "id": "10665-353150",
    "type": "book",
    "title": "Guide d’investissement pour la mise en oeuvre numérique (DIIG) : intégrer les interventions numériques dans les programmes de santé",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          4,
          14
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9789240047556 (version électronique)",
    "URL": "https://iris.who.int/handle/10665/353150",
    "language": "fr"
  },
  {
    "id": "10665-354400",
    "type": "book",
    "title": "Lignes directrices de l'OMS : recommandations sur les interventions numériques pour le renforcement des systèmes de santé",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          5,
          19
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9789240046641 (version électronique)",
    "URL": "https://iris.who.int/handle/10665/354400",
    "language": "fr",
    "abstract": "Ces lignes directrices de l’OMS présentent des recommandations fondées sur des données probantes concernant l’utilisation des interventions numériques pour renforcer les systèmes de santé et soutenir les progrès vers la couverture sanitaire universelle (CSU). Élaborées en réponse à l’adoption croissante des technologies numériques et à la résolution sur la santé numérique approuvée par l’Assemblée mondiale de la Santé en 2018, elles répondent à la nécessité d’évaluer rigoureusement les interventions de santé numérique afin que les investissements reposent sur des données probantes relatives à leurs avantages, leurs inconvénients, leur acceptabilité, leur faisabilité, leurs implications en matière de ressources et les considérations d’équité. Les lignes directrices soulignent que les technologies numériques doivent compléter, et non remplacer, les composantes fondamentales de systèmes de santé performants.\n\nLes recommandations portent sur un ensemble prioritaire d’interventions de santé numérique, principalement accessibles au moyen d’appareils mobiles, notamment la notification des naissances et des décès, la notification des stocks et la gestion des produits de base, la télémédecine entre client et prestataire ainsi qu’entre prestataires, la communication ciblée avec les clients, le suivi numérique de l’état de santé et des services reçus, les outils d’aide à la décision destinés aux professionnels de santé et l’apprentissage numérique. Les lignes directrices présentent également des considérations relatives à la mise en œuvre, recensent les principales lacunes en matière de recherche et visent à aider les ministères de la santé, les responsables des politiques de santé, les professionnels de santé, les partenaires du développement et les autres parties prenantes à prendre des décisions éclairées concernant l’adoption, le déploiement à grande échelle et l’institutionnalisation des interventions de santé numérique efficaces."
  },
  {
    "id": "10665-378873",
    "type": "book",
    "title": "Classification des interventions, des services et des applications numériques dans le domaine de la santé : un langage commun pour décrire les diverses utilisations de la technologie numérique dans le domaine de la santé",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2024,
          9,
          12
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9789240093720 (version électronique)",
    "URL": "https://iris.who.int/handle/10665/378873",
    "language": "fr",
    "abstract": "Cette deuxième édition de la Classification des interventions, services et applications numériques en santé présente une taxonomie normalisée permettant de décrire la manière dont les technologies numériques sont utilisées pour répondre aux besoins des individus et des systèmes de santé. Élaborée par l’OMS, cette classification établit un langage commun destiné à faciliter la communication entre les décideurs, les responsables de programmes de santé, les chercheurs, les responsables de mise en œuvre, les développeurs de technologies et les autres acteurs du domaine de la santé numérique. Elle organise les interventions numériques en santé autour de capacités technologiques distinctes conçues pour répondre à des défis des systèmes de santé et relie ces interventions aux services et types d’applications numériques qui les mettent en œuvre.\n\nLa publication met à jour et élargit la première édition publiée en 2018 afin de refléter les progrès des technologies de santé numérique, l’évolution des pratiques de mise en œuvre et les enseignements tirés de leur utilisation à l’échelle mondiale. Le cadre est structuré autour de trois axes interconnectés : les défis des systèmes de santé, les interventions numériques en santé et les services et types d’applications numériques. Il comprend des interventions destinées aux personnes, aux prestataires de soins, aux gestionnaires des systèmes de santé et aux services de données, ainsi que des catégories d’applications numériques et de systèmes d’information. Cette classification vise à soutenir la planification, la mise en œuvre, l’analyse des investissements, la recherche, l’interopérabilité, l’élaboration des politiques et la gouvernance des initiatives de santé numérique."
  },
  {
    "id": "10665-387553",
    "type": "report",
    "title": "Stratégie régionale pour améliorer l'accès aux médicaments et aux vaccins dans la Méditerranée orientale, pour la période 2020-2030 : accélérer la mise en oeuvre grâce à des systèmes de réglementation plus solides",
    "author": [
      {
        "literal": "Organisation mondiale de la Santé. Bureau régional de la Méditerranée orientale"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2026,
          9,
          15
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé. Bureau régional de la Méditerranée orientale",
    "URL": "https://iris.who.int/handle/10665/387553",
    "language": "fr"
  },
  {
    "id": "10665-344251",
    "type": "book",
    "title": "Estrategia mundial sobre salud digital 2020–2025",
    "author": [
      {
        "literal": "Organización Mundial de la Salud"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          8,
          18
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "ISBN": "9789240027572 (versión electrónica)",
    "URL": "https://iris.who.int/handle/10665/344251",
    "language": "es",
    "abstract": "La Estrategia mundial sobre salud digital 2020–2025 proporciona un marco para apoyar a los Estados Miembros en el fortalecimiento de los sistemas de salud mediante la adopción y el uso adecuados de las tecnologías digitales. Elaborada en respuesta a los mandatos de la Asamblea Mundial de la Salud y alineada con los Objetivos de Desarrollo Sostenible y las metas de los “Tres Mil Millones” de la OMS, la estrategia establece una visión compartida para mejorar la salud y el bienestar a través de soluciones de salud digital accesibles, asequibles, seguras y sostenibles. Destaca la importancia de una gobernanza sólida, la interoperabilidad, el uso ético de los datos, la protección de la privacidad, el fortalecimiento de las capacidades del personal sanitario y la inversión en infraestructura digital para apoyar las prioridades nacionales de salud y la cobertura sanitaria universal.\n\nEl documento define cuatro objetivos estratégicos: promover la colaboración mundial y el intercambio de conocimientos; avanzar en la implementación de estrategias nacionales de salud digital; fortalecer la gobernanza de la salud digital a nivel mundial, regional y nacional; y fomentar sistemas de salud centrados en las personas mediante el uso de tecnologías digitales. Asimismo, presenta principios rectores, un marco de implementación y mecanismos de seguimiento destinados a apoyar a los países en el desarrollo de ecosistemas de salud digital interoperables. Se presta especial atención a los obstáculos que enfrentan los países de ingresos bajos y medianos y a garantizar que la transformación digital contribuya a sistemas de salud más equitativos, eficaces y resilientes."
  },
  {
    "id": "10665-341918",
    "type": "report",
    "title": "La OMS recomienda la adopción de enfoques basados en las redes de contactos para la realización de pruebas del VIH en los grupos de población clave, en el marco de un conjunto de servicios para las parejas: sinopsis de políticas",
    "author": [
      {
        "literal": "Organización Mundial de la Salud"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          6,
          22
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/341918",
    "language": "es"
  },
  {
    "id": "10665-338849",
    "type": "report",
    "title": "Recomendaciones provisionales para utilizar la vacuna contra la COVID-19 elaborada por Pfizer y BioNTech, BNT162b2, en el marco de la lista de uso en emergencias: orientaciones provisionales, 8 de enero de 2021",
    "author": [
      {
        "literal": "Organización Mundial de la Salud"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          1,
          25
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/338849",
    "language": "es"
  },
  {
    "id": "10665-354399",
    "type": "book",
    "title": "Directriz de la OMS: recomendaciones sobre intervenciones digitales para fortalecer los sistemas de salud",
    "author": [
      {
        "literal": "Organización Mundial de la Salud"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          5,
          19
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "ISBN": "9789240046993 (versión electrónica)",
    "URL": "https://iris.who.int/handle/10665/354399",
    "language": "es",
    "abstract": "Este documento presenta las recomendaciones de la OMS, basadas en la evidencia, sobre el uso de intervenciones digitales para fortalecer los sistemas de salud y apoyar el avance hacia la cobertura sanitaria universal (CSU). Elaborada en respuesta a la creciente adopción de las tecnologías digitales y a la resolución sobre salud digital aprobada por la Asamblea Mundial de la Salud en 2018, la directriz aborda la necesidad de evaluar rigurosamente las intervenciones de salud digital para garantizar que las inversiones se fundamenten en evidencia sobre sus beneficios, riesgos, aceptabilidad, factibilidad, implicaciones en materia de recursos y consideraciones de equidad. Asimismo, subraya que las tecnologías digitales deben complementar, y no sustituir, los componentes fundamentales de unos sistemas de salud sólidos y eficaces.\n\nLas recomendaciones se centran en un conjunto priorizado de intervenciones de salud digital accesibles, como mínimo, mediante dispositivos móviles, entre ellas la notificación de nacimientos y defunciones, la notificación de existencias y la gestión de suministros, la telemedicina entre pacientes y profesionales y entre profesionales, la comunicación dirigida a los pacientes, el seguimiento digital del estado de salud y de los servicios recibidos, las herramientas de apoyo a la toma de decisiones para el personal sanitario y el aprendizaje digital para los trabajadores de la salud. La directriz también presenta consideraciones para la implementación, identifica las principales lagunas de investigación y proporciona orientación a los ministerios de salud, los responsables de salud pública, los asociados para el desarrollo y otras partes interesadas para adoptar, ampliar e institucionalizar intervenciones de salud digital eficaces sobre la base de la mejor evidencia disponible."
  },
  {
    "id": "10665-353151",
    "type": "book",
    "title": "Guía para la inversión en la implementación digital (DIIG): incorporación de intervenciones digitales en los programas de salud",
    "author": [
      {
        "literal": "Organización Mundial de la Salud"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          4,
          14
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "ISBN": "9789240047570 (versión electrónica)",
    "URL": "https://iris.who.int/handle/10665/353151",
    "language": "es"
  },
  {
    "id": "10665-379033",
    "type": "book",
    "title": "Clasificación de intervenciones, servicios y aplicaciones digitales en salud: un lenguaje compartido para describir los usos de la tecnología digital para la salud",
    "author": [
      {
        "literal": "Organización Mundial de la Salud"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2024,
          9,
          24
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "ISBN": "9789240093744 (versión electrónica)",
    "URL": "https://iris.who.int/handle/10665/379033",
    "language": "es",
    "abstract": "Esta segunda edición de la Clasificación de intervenciones, servicios y aplicaciones digitales en salud proporciona una taxonomía normalizada para describir cómo se utilizan las tecnologías digitales para responder a las necesidades de las personas y de los sistemas de salud. Desarrollada por la OMS, la clasificación establece un lenguaje común destinado a facilitar la comunicación entre responsables de la formulación de políticas, gestores de programas de salud, investigadores, implementadores, desarrolladores tecnológicos y otras partes interesadas en la salud digital. Organiza las intervenciones de salud digital en torno a capacidades tecnológicas específicas diseñadas para abordar desafíos de los sistemas de salud y las vincula con los servicios digitales y los tipos de aplicaciones mediante los cuales se prestan.\n\nLa publicación actualiza y amplía la primera edición, publicada en 2018, para reflejar los avances en las tecnologías de salud digital, la evolución de las prácticas de implementación y las lecciones aprendidas a partir de su utilización a nivel mundial. El marco se estructura en torno a tres ejes interrelacionados: los desafíos de los sistemas de salud, las intervenciones de salud digital y los tipos de servicios y aplicaciones digitales. Incluye intervenciones dirigidas a las personas, los proveedores de atención sanitaria, los gestores de sistemas de salud y los servicios de datos, junto con categorías de aplicaciones digitales y sistemas de información. La clasificación está concebida para apoyar la planificación, la implementación, el análisis de inversiones, la investigación, las consideraciones de interoperabilidad, la elaboración de políticas y la gobernanza de las iniciativas de salud digital, facilitando así un uso más coherente y eficaz de las tecnologías digitales en los sistemas de salud."
  },
  {
    "id": "10665-249224",
    "type": "report",
    "title": "Programme élargi de vaccination (résolution)",
    "issued": {
      "date-parts": [
        [
          2014,
          12,
          31
        ]
      ]
    },
    "publisher": "Bureau régional de l'OMS pour le Pacifique occidental",
    "URL": "https://iris.who.int/handle/10665/249224",
    "language": "Français"
  },
  {
    "id": "10665-249126",
    "type": "report",
    "title": "Rapport de situation sur les programmes techniques : lutte antitabac ; cadres de vie sains ; maladies non transmissibles ; Objectifs du Millénaire pour le développement liés à la santé ; financement de la santé ; paludisme et résistance à l'artémisinine ; Programme élargi de vaccination ; prévention et traitement du VIH/sida",
    "issued": {
      "date-parts": [
        [
          2012,
          12,
          31
        ]
      ]
    },
    "publisher": "Bureau régional de l’OMS pour le Pacifique occidental",
    "URL": "https://iris.who.int/handle/10665/249126",
    "language": "Français"
  },
  {
    "id": "10665-92871",
    "type": "document",
    "title": "Way and Means of Implementing Resolutions of Regional Interest Adopted by the World Health Assembly and the Executive Board  Report of the Regional Director",
    "author": [
      {
        "family": "Regional Committee for Africa",
        "given": "54"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for Africa",
    "URL": "https://iris.who.int/handle/10665/92871",
    "language": "en",
    "abstract": "1. The Fifty-seventh World Health Assembly and the one-hundred-and-thirteenth sessionof the Executive Board adopted resolutions on certain issues of regional interest as set outbelow:(a) Surveillance and control of Mycobacterium ulcerans disease (Buruli ulcer)(WHA57.1)(b) Control of human African trypanosomiasis (WHA57.2)(c) Eradication of dracunculiasis (WHA57.9)(d) Road safety and health (WHA57.10)(e) Family and health in the context of the tenth anniversary of the International Yearof the Family (WHA57.11)(f) Reproductive health: Draft strategy to accelerate progress towards the attainmentof international development goals and targets (WHA57.12)(g) Genomics and world health (WHA57.13)(h) Scaling up treatment and care within a coordinated and comprehensive response toHIV/AIDS (WHA57.14)(i) Health promotion and healthy lifestyles (WHA57.16)(j) Global strategy on diet, physical activity and health (WHA57.17)(k) Human organ and tissue transplantation (WHA57.18)(l) International migration of health personnel: A challenge for health systems indeveloping countries (WHA57.19)"
  },
  {
    "id": "10665-57150",
    "type": "document",
    "title": "Reports on individual drugs",
    "issued": {
      "date-parts": [
        [
          1999,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/57150",
    "language": "en"
  },
  {
    "id": "10665-47547",
    "type": "document",
    "title": "HIV : to test or not to test?",
    "author": [
      {
        "family": "Sartorius",
        "given": "Norman"
      },
      {
        "family": "Bailey",
        "given": "Pearl"
      },
      {
        "family": "Carrasco",
        "given": "Ignazio"
      },
      {
        "family": "Castro",
        "given": "Emilio"
      },
      {
        "family": "Dawson",
        "given": "John"
      },
      {
        "family": "Dembelé",
        "given": "M."
      },
      {
        "family": "Garai",
        "given": "François"
      },
      {
        "family": "Keilau",
        "given": "H."
      },
      {
        "family": "Kirby",
        "given": "Michael"
      },
      {
        "family": "Kouchner",
        "given": "Bernard"
      },
      {
        "family": "Pokrovski",
        "given": "Vladimir"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1989,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/47547",
    "language": "en"
  },
  {
    "id": "10665-261545",
    "type": "document",
    "title": "WHO international quality assessment scheme for HIV antibody testing: results from the second distribution of sera.",
    "author": [
      {
        "family": "Snell",
        "given": "J. J."
      },
      {
        "family": "Supran",
        "given": "E. M."
      },
      {
        "family": "Tamashiro",
        "given": "H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1992,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/261545",
    "language": "en"
  },
  {
    "id": "10665-72461",
    "type": "document",
    "title": "La supplémentation en iode par voie buccale ne réduit pas la réponse en anticorps neutralisants au vaccin  antipoliomyélitique buccal / R. E. Taffs ... [et al.]",
    "author": [
      {
        "family": "Taffs",
        "given": "R. E"
      },
      {
        "family": "Enterline",
        "given": "J. C"
      },
      {
        "family": "Rusmil",
        "given": "K"
      },
      {
        "literal": "Muhilal"
      },
      {
        "family": "Suwardi",
        "given": "S. S"
      },
      {
        "family": "Rustama",
        "given": "D"
      },
      {
        "literal": "Djatnika"
      },
      {
        "family": "Cobra",
        "given": "C"
      },
      {
        "family": "Semba",
        "given": "R. D"
      },
      {
        "family": "Cohen",
        "given": "N"
      },
      {
        "family": "Asher",
        "given": "D. M"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1999,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/72461",
    "language": "fr"
  },
  {
    "id": "10665-47160",
    "type": "document",
    "title": "Les maladies transmissibles / Giorgio Torrigiani et William Parra",
    "author": [
      {
        "family": "Torrigiani",
        "given": "Giorgio"
      },
      {
        "family": "Parra",
        "given": "William"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1988,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/47160"
  },
  {
    "id": "10665-266967",
    "type": "document",
    "title": "The value of duck-embryo vaccine and high-egg-passage Flury vaccine in experimental rabies infection in guinea-pigs",
    "author": [
      {
        "family": "Veeraraghavan",
        "given": "N."
      },
      {
        "family": "Subrahmanyan",
        "given": "T. P."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1963,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/266967",
    "language": "en"
  },
  {
    "id": "10665-270157",
    "type": "document",
    "title": "Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals",
    "author": [
      {
        "family": "Wanyenze",
        "given": "Rhoda K"
      },
      {
        "family": "Nawavvu",
        "given": "Cecilia"
      },
      {
        "family": "Namale",
        "given": "Alice S"
      },
      {
        "family": "Mayanja",
        "given": "Bernard"
      },
      {
        "family": "Bunnell",
        "given": "Rebecca"
      },
      {
        "family": "Abang",
        "given": "Betty"
      },
      {
        "family": "Amanyire",
        "given": "Gideon"
      },
      {
        "family": "Sewankambo",
        "given": "Nelson K"
      },
      {
        "family": "Kamya",
        "given": "Moses R"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          4,
          1
        ]
      ]
    },
    "publisher": "World Health Organization",
    "DOI": "10.2471/BLT.07.042580",
    "URL": "https://iris.who.int/handle/10665/270157",
    "language": "en"
  },
  {
    "id": "10665-37905",
    "type": "book",
    "title": "Accélération des activités de vaccination : principes de planification / déclaration conjointe OMS/FISE",
    "author": [
      {
        "literal": "WHO Expanded Programme on Immunization"
      },
      {
        "literal": "United Nations Children's Fund (UNICEF)"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1985,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "ISBN": "9242560871",
    "URL": "https://iris.who.int/handle/10665/37905",
    "language": "en"
  },
  {
    "id": "10665-58534",
    "type": "document",
    "title": "Counselling for HIV/AIDS : a key to caring, for policy-makers, planners and implementors of counselling activities",
    "author": [
      {
        "literal": "WHO Global Programme on AIDS"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1995,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/58534",
    "language": "en"
  },
  {
    "id": "10665-162250",
    "type": "document",
    "title": "Fourth report of Committee A",
    "author": [
      {
        "family": "World Health Assembly",
        "given": "39"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1986,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/162250",
    "language": "en"
  },
  {
    "id": "10665-279505",
    "type": "document",
    "title": "Digital health",
    "author": [
      {
        "family": "World Health Assembly",
        "given": "71"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/279505",
    "language": "en"
  },
  {
    "id": "10665-239877",
    "type": "document",
    "title": "INOCULATION AND VACCINATION CERTIFICATES REQUIRED BY VARIOUS COUNTRIES = CERTIFICATS DE VACCINATION EXIGÉS_x000D_ PAR LES DIVERS PAYS",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1951,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/239877",
    "language": "en"
  },
  {
    "id": "10665-209008",
    "type": "document",
    "title": "VACCINATION CERTIFICATES REQUIRED BY VARIOUS COUNTRIES = CERTIFICATS DE VACCINATlON EXIGÉS PAR LES DIVERS PAYS",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1953,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/209008",
    "language": "en"
  },
  {
    "id": "10665-209646",
    "type": "document",
    "title": "YELLOW FEVER : DESIGNATED VACCINATING CENTRES = FIÈVRE JAUNE : CENTRES DE VACCINATION HABILITÉS",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1954,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/209646",
    "language": "en"
  },
  {
    "id": "10665-211583",
    "type": "document",
    "title": "YELLOW FEVER : DESIGNATED VACCINATING CENTRES = FIÈVRE JAUNE : CENTRES DE VACCINATION HABILITÉS",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1958,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/211583",
    "language": "en"
  },
  {
    "id": "10665-214276",
    "type": "document",
    "title": "YELLOW FEVER : DESIGNATED VACCINATING CENTRES = FIÈVRE JAUNE : CENTRES DE VACCINATION HABILITÉS",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1964,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/214276",
    "language": "en"
  },
  {
    "id": "10665-215678",
    "type": "document",
    "title": "SANITARY MEASURES : VACCINATION CERTIFICATE REQUIREMENTS FOR INTERNATIONAL TRAVEL = MESURES SANITAIRES : CERTIFICATS DE VACCINATION EXIGÉS DANS LES VOYAGES INTERNATIONAUX",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1966,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/215678",
    "language": "en"
  },
  {
    "id": "10665-68008",
    "type": "document",
    "title": "Country report : country, Upper Volta",
    "author": [
      {
        "literal": "World Health Organization"
      },
      {
        "family": "Inter-Regional Seminar on Smallpox Eradication (1969 : Lagos",
        "given": "Nigeria)"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1969,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/68008",
    "language": "en"
  },
  {
    "id": "10665-217807",
    "type": "document",
    "title": "YELLOW-FEVER VACCINATING CENTRES _x000D_FOR INTERNATIONAL TRAVEL = CENTRES DE VACCINATION CONTRE LA FIÈVRE JAUNE POUR LES VOYAGES INTERNATIONAUX",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1970,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/217807",
    "language": "en"
  },
  {
    "id": "10665-218295",
    "type": "document",
    "title": "IMMUNIZATION SURVEY - 1970 = ENQUÊTE SUR LES VACCINATIONS — 1970",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1971,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/218295",
    "language": "en"
  },
  {
    "id": "10665-218508",
    "type": "document",
    "title": "VACCINATION CERTIFICATE REQUIREMENTS FOR INTERNATIONAL TRAVEL = CERTIFICATS DE VACCINATION EXIGÉS_x000D_DANS LES VOYACES INTERNATIONAUX",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1971,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/218508",
    "language": "en"
  },
  {
    "id": "10665-218202",
    "type": "document",
    "title": "YELLOW-FEVER VACCINATING CENTRES_x000D_FOR INTERNATIONAL TRAVEL = CENTRES DE VACCINATION CONTRE LA FIÈVRE JAUNE POUR LES VOYAGES INTERNATIONAUX",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1971,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/218202",
    "language": "en"
  },
  {
    "id": "10665-220134",
    "type": "document",
    "title": "VACCINATION CERTIFICATE REQUIREMENTS FOR INTERNATIONAL TRAVEL = CERTIFICATS DE VACCINATION EXIGÉS DANS LES VOYAGES INTERNATIONAUX",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1974,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/220134",
    "language": "en"
  },
  {
    "id": "10665-220369",
    "type": "document",
    "title": "YELLOW-FEVER VACCINATING CENTRES_x000D_FOR INTERNATIONAL TRAVEL : Amendments to 1974 publication = CENTRES DE VACCINATION CONTRE LA FIÈVRE JAUNE POUR LES VOYAGES INTERNATIONAUX : Amendements à la publication de 1974",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1975,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/220369",
    "language": "en"
  },
  {
    "id": "10665-222160",
    "type": "document",
    "title": "MENINGOCOCCAL POLYSACCHARIDE VACCINES = VACCINS ANTIMÉNINGOCOCCIQUES POLYOSIDIQUES",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1978,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/222160",
    "language": "en"
  },
  {
    "id": "10665-230330",
    "type": "document",
    "title": "Expanded Programme on Immunization (EPI) : Progress towards poliomyelitis eradication, WHO Western Pacific Region, January 1996-September 1997 = Programme élargi de vaccination (PEV) : Progrès réalisés vers l’éradication de la poliomyélite, Région OMS du Pacifique occidental, janvier 1996-septembre 1997",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1997,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/230330",
    "language": "en"
  },
  {
    "id": "10665-231031",
    "type": "document",
    "title": "Thiomersal as a vaccine preservative = L’utilisation du thiomersal comme conservateur pour vaccins",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2000,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/231031",
    "language": "en"
  },
  {
    "id": "10665-67132",
    "type": "document",
    "title": "Breastfeeding and replacement feeding practices in the context of mother-to-child transmission of HIV : an assessment tool for research",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/67132",
    "language": "en"
  },
  {
    "id": "10665-66977",
    "type": "document",
    "title": "Hepatitis B immunization : introducing hepatitis B vaccine into national immunization services",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/66977",
    "language": "ar"
  },
  {
    "id": "10665-42458",
    "type": "book",
    "title": "Herpes simplex virus type 2 : programmatic and research priorities in developing countries : report of a WHO/UNAIDS/LSHTM workshop, London, 14-16 February 2001",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9291731447",
    "URL": "https://iris.who.int/handle/10665/42458",
    "language": "en"
  },
  {
    "id": "10665-67212",
    "type": "document",
    "title": "Inmunización contra la Hepatitis B : introducción de la vacuna contra la hepatitis B en los servicios nacionales de inmunización",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          12,
          31
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/67212",
    "language": "ar"
  },
  {
    "id": "10665-67211",
    "type": "document",
    "title": "Vaccination contre l' hépatite B : introduire le vaccin contre l' hépatite B dans les services nationaux de vaccination",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/67211",
    "language": "ar"
  },
  {
    "id": "10665-67344",
    "type": "document",
    "title": "Prevention of HIV in infants and young children : review of evidence and WHO's activities",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2002,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/67344",
    "language": "en"
  },
  {
    "id": "10665-232378",
    "type": "document",
    "title": "OUTBREAK NEWS : Development of a vaccine effective against avian influenza H5N1 infection in humans",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/232378",
    "language": "ar"
  },
  {
    "id": "10665-69096",
    "type": "document",
    "title": "Pre-qualification of single-use injection devices under the PQS system : a guideline for manufacturers",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/69096",
    "language": "en"
  },
  {
    "id": "10665-69034",
    "type": "document",
    "title": "The immunization data quality self-assessment (DSQ) tool",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/69034",
    "language": "en"
  },
  {
    "id": "10665-69653",
    "type": "document",
    "title": "Phase préparatoire à l' instauration de la vaccination anti-papillomavirus : directives stratégiques à l' intention des pays",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          12,
          31
        ]
      ]
    },
    "publisher": "Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/69653",
    "language": "ar"
  },
  {
    "id": "10665-69654",
    "type": "document",
    "title": "Preparación de las introducción de las vacunas contra el virus del papiloma humano : orientaciones normativas y programáticas para los países",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          12,
          31
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "URL": "https://iris.who.int/handle/10665/69654",
    "language": "ar"
  },
  {
    "id": "10665-69384",
    "type": "document",
    "title": "Preparing for the introduction of HPV vaccines : policy and programme guidance for countries",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/69384",
    "language": "ar"
  },
  {
    "id": "WER8207_51-60",
    "type": "document",
    "title": "Mumps virus vaccines = Vaccins anti-ourliens",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/240868",
    "language": "en"
  },
  {
    "id": "10665-43699",
    "type": "book",
    "title": "WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241595629",
    "URL": "https://iris.who.int/handle/10665/43699",
    "language": "en"
  },
  {
    "id": "10665-102762",
    "type": "report",
    "title": "Gateways to integration : a case study from Swaziland: in support of the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive",
    "author": [
      {
        "literal": "World Health Organization"
      },
      {
        "literal": "United Nations Population Fund"
      },
      {
        "literal": "UNAIDS"
      },
      {
        "literal": "International Planned Parenthood Federation"
      },
      {
        "literal": "Swaziland. Ministry of Health"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/102762",
    "language": "en"
  },
  {
    "id": "WER8647_521-539",
    "type": "document",
    "title": "Meningococcal vaccines : WHO position paper, November 2011 = Note de synthèse : position de l’OMS sur les vaccins antiméningococciques, novembre 2011",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/241846",
    "language": "en"
  },
  {
    "id": "10665-44796",
    "type": "book",
    "title": "Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241503082",
    "URL": "https://iris.who.int/handle/10665/44796",
    "language": "en"
  },
  {
    "id": "10665-44759",
    "type": "book",
    "title": "Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241502672",
    "URL": "https://iris.who.int/handle/10665/44759",
    "language": "en",
    "abstract": "This policy statement provides evidence-based recommendations on the use of commercial interferon-gamma release assays (IGRAs) for tuberculosis (TB) in low- and middle-income countries, particularly settings with a high TB and/or HIV burden. Based on systematic reviews and GRADE assessment, it evaluates IGRAs for diagnosis of active TB, detection of latent TB infection (LTBI) in children and people living with HIV, screening of health care workers and contacts, outbreak investigations, and prediction of progression to active disease.\n\nThe evidence was generally of low or very low quality and did not demonstrate superior performance of IGRAs over the tuberculin skin test (TST). WHO recommends that IGRAs and the TST not be used to diagnose active TB or identify individuals at risk of developing active disease, and that IGRAs not replace the TST for LTBI diagnosis in children, people living with HIV, or contacts. Given comparable performance, greater cost and technical complexity, replacing the TST with IGRAs as a public health intervention in resource-constrained settings is not recommended."
  },
  {
    "id": "WER8624_241-256",
    "type": "document",
    "title": "Vaccines against tick-borne encephalitis : WHO position paper = Note de synthèse : position de l'OMS sur les vaccins contre l'encéphalite à tiques",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/241769",
    "language": "en"
  },
  {
    "id": "10665-44853",
    "type": "book",
    "title": "Cadre de préparation en cas de grippe pandémique pour l'échange des virus grippaux et l'accès aux vaccins et autres avantages",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          6,
          16
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789242503081",
    "URL": "https://iris.who.int/handle/10665/44853",
    "language": "en"
  },
  {
    "id": "10665-75211",
    "type": "book",
    "title": "National eHealth strategy toolkit",
    "author": [
      {
        "literal": "World Health Organization"
      },
      {
        "literal": "International Telecommunication Union"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          7,
          31
        ]
      ]
    },
    "publisher": "International Telecommunication Union",
    "ISBN": "9789241548465 (WHO)",
    "URL": "https://iris.who.int/handle/10665/75211",
    "language": "en"
  },
  {
    "id": "10665-44867",
    "type": "book",
    "title": "Preparación para una gripe pandémica:  marco para el intercambio de virus gripales y el acceso a las vacunas y otros beneficios",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          6,
          16
        ]
      ]
    },
    "publisher": "Organización Mundial de la Salud",
    "ISBN": "9789243503080",
    "URL": "https://iris.who.int/handle/10665/44867",
    "language": "en"
  },
  {
    "id": "10665-77764",
    "type": "book",
    "title": "WHO recommendations: optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          12,
          19
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241504843",
    "URL": "https://iris.who.int/handle/10665/77764",
    "language": "en",
    "abstract": "This WHO guidance provides evidence-based recommendations on optimizing health worker roles through task shifting to improve universal access to key maternal and newborn health interventions. Developed in response to health workforce shortages and inequities in access to care, it assesses whether specific interventions can be delivered safely and effectively by different health worker cadres, including lay health workers, auxiliary nurses and nurse midwives, nurses, midwives, associate clinicians, advanced level associate clinicians and non-specialist doctors.\n\nThe guidance presents 119 recommendations, ranging from practices recommended for implementation to those requiring targeted monitoring and evaluation, rigorous research, or not recommended. It emphasizes that task shifting should complement efforts to increase skilled care and should aim to expand access while maintaining safety. Implementation should consider health-system capacity and local sociocultural, political and financial conditions, with recommendations adapted through national dialogue and considered as packages of interventions rather than in isolation."
  },
  {
    "id": "10665-90448",
    "type": "book",
    "title": "Guiding principles on ethical issues in HIV surveillance",
    "author": [
      {
        "literal": "World Health Organization"
      },
      {
        "literal": "UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          10,
          10
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241505598",
    "URL": "https://iris.who.int/handle/10665/90448",
    "language": "en"
  },
  {
    "id": "WER8839_413-426",
    "type": "document",
    "title": "Haemophilus influenzae type b (Hib) Vaccination Position Paper — July 2013 : Introduction = Note de synthèse : Position de l’OMS sur la vaccination anti-Haemophilus influenzae type b (Hib) — Juillet 2013 : Introduction",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/242126",
    "language": "en"
  },
  {
    "id": "WER8827_269-283",
    "type": "document",
    "title": "Vaccines and vaccination against yellow fever : WHO Position Paper — June 2013 = Note de synthèse : position de l’OMS sur les vaccins et la vaccination contre la fièvre jaune, juin 2013",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/242089",
    "language": "en"
  },
  {
    "id": "10665-94830",
    "type": "book",
    "title": "WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          11,
          19
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241548694",
    "URL": "https://iris.who.int/handle/10665/94830",
    "language": "en",
    "abstract": "These guidelines provide recommendations for screen-and-treat strategies to prevent cervical cancer by detecting and treating precancerous cervical lesions. The screen-and-treat approach bases treatment decisions on screening results, allowing treatment soon or ideally immediately after a positive test, rather than requiring histological confirmation. The guidelines compare strategies using human papillomavirus (HPV) testing, visual inspection with acetic acid (VIA), and cytology, linked to treatment with cryotherapy or loop electrosurgical excision procedure (LEEP). They are intended primarily to support policy-makers, programme managers and other health professionals in selecting appropriate cervical cancer prevention strategies according to available resources and existing programmes.\n\nNine recommendations are provided. HPV-based screening is generally preferred where feasible, while VIA is suggested where HPV testing is not feasible; cold knife conization is not recommended as part of a screen-and-treat strategy. Recommendations apply to all women, with specific guidance for women living with HIV. Decision-making and implementation flowcharts support adaptation of the recommended strategies to country and regional contexts."
  },
  {
    "id": "WER8925_265-287",
    "type": "document",
    "title": "Varicella and herpes zoster vaccines : WHO position paper, June 2014 = Vaccins contre la varicelle et le zona : note de synthèse de l’OMS, juin 2014",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/242227",
    "language": "en"
  },
  {
    "id": "9789241548960-eng",
    "type": "book",
    "title": "WHO handbook for guideline development",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          12,
          18
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241548960",
    "URL": "https://iris.who.int/handle/10665/145714",
    "language": "en",
    "abstract": "This handbook provides comprehensive guidance on the planning, development, publication, implementation, adaptation and updating of WHO guidelines. Intended for WHO technical units, guideline developers, members of guideline development and external review groups, and other contributors, it describes the principles, methods and governance processes required to produce transparent, evidence-informed recommendations for clinical practice and public health policy that meet WHO standards."
  },
  {
    "id": "10665-196326",
    "type": "book",
    "title": "Ethics in epidemics, emergencies and disasters: research, surveillance and patient care: training manual",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          11,
          20
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9787117270182 (Chinese)",
    "URL": "https://iris.who.int/handle/10665/196326",
    "language": "en"
  },
  {
    "id": "WER9035_433-458",
    "type": "document",
    "title": "Pertussis vaccines : WHO position paper — August 2015 = Note de synthèse : Position de l’OMS concernant les vaccins anticoquelucheux — août 2015",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          12,
          31
        ]
      ]
    },
    "URL": "https://iris.who.int/handle/10665/242413",
    "language": "en"
  },
  {
    "id": "9789241509510-eng",
    "type": "book",
    "title": "The MAPS toolkit: mHealth assessment and planning for scale",
    "author": [
      {
        "literal": "World Health Organization"
      },
      {
        "literal": "United Nations Foundation"
      },
      {
        "family": "UNDP/UNFPA/WHO/World Bank Special Programme of Research",
        "given": "Development and Research Training in Human Reproduction"
      },
      {
        "literal": "Johns Hopkins University"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          9,
          23
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241509510",
    "URL": "https://iris.who.int/handle/10665/185238",
    "language": "en"
  },
  {
    "id": "9789241549684_eng",
    "type": "book",
    "title": "Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          6,
          6
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241549684",
    "URL": "https://iris.who.int/handle/10665/208825",
    "language": "en",
    "abstract": "This evidence-based guideline consolidates World Health Organization recommendations on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection, providing a comprehensive public health framework for HIV diagnosis, prevention, treatment, service delivery, and monitoring and evaluation across all age groups and populations. Developed in response to advances in scientific evidence and evolving programmatic needs, the second edition updates the 2013 consolidated guidelines and incorporates new recommendations, including universal eligibility for antiretroviral therapy (ART) regardless of CD4 cell count, expanded use of pre-exposure prophylaxis, and optimized approaches to HIV testing, treatment monitoring and management of coinfections and comorbidities. The guideline also outlines the methods used for guideline development and the principles underpinning a public health approach.\n\nThe publication provides evidence-based recommendations on HIV testing services, antiretroviral therapy, prevention interventions, differentiated service delivery models, linkage to care, adherence, decentralization, task sharing, laboratory services and programme monitoring. It emphasizes integrated, people-centred and community-based approaches to improve access to high-quality HIV services, strengthen health systems and support implementation in diverse epidemiological settings. Intended primarily for national HIV programme managers, clinicians, policy-makers and implementing partners, the guideline aims to accelerate progress towards universal access to HIV services and the global goal of ending the HIV epidemic as a major public health threat by 2030."
  },
  {
    "id": "9789241511766-eng",
    "type": "book",
    "title": "Monitoring and evaluating digital health interventions: a practical guide to conducting research and assessment",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          13
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241511766",
    "URL": "https://iris.who.int/handle/10665/252183",
    "language": "en"
  },
  {
    "id": "10665-249154",
    "type": "book",
    "title": "The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          8,
          8
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241511186",
    "URL": "https://iris.who.int/handle/10665/249154",
    "language": "en",
    "abstract": "Tuberculosis remains a major global public health challenge, and the WHO End TB Strategy emphasizes the need for early diagnosis and universal drug-susceptibility testing. This policy guidance presents evidence-based recommendations on the use of the commercial loop-mediated isothermal amplification assay (TB-LAMP) for the diagnosis of pulmonary tuberculosis. Developed following a systematic review of studies conducted since 2012 and assessment using the GRADE approach, the document evaluates the diagnostic accuracy of TB-LAMP as a replacement for sputum-smear microscopy, as an add-on test after negative smear microscopy, and in comparison with the Xpert MTB/RIF assay, while also assessing the frequency of indeterminate or invalid results.\n\nBased on the available evidence, WHO recommends that TB-LAMP may be used as a replacement for sputum-smear microscopy in adults with signs and symptoms of pulmonary tuberculosis and as a follow-on test when further investigation of smear-negative specimens is required. The guidance emphasizes that these conditional recommendations are based on very low-quality evidence, apply to sputum specimens from patients with suspected pulmonary tuberculosis, and should not replace rapid molecular tests capable of detecting rifampicin resistance. It also highlights the limited evidence for use in people living with HIV, notes the extrapolation of recommendations to children, and provides implementation considerations and priorities for future research."
  },
  {
    "id": "9789241549912-eng",
    "type": "book",
    "title": "WHO recommendations on antenatal care for a positive pregnancy experience",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          11,
          7
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241549912",
    "URL": "https://iris.who.int/handle/10665/250796",
    "language": "en",
    "abstract": "This guideline presents the World Health Organization’s evidence-based recommendations on routine antenatal care to support a positive pregnancy experience for pregnant women and adolescent girls. It aims to provide a comprehensive, consolidated framework for antenatal care that complements existing WHO guidance on the management of specific pregnancy-related complications. The recommendations promote a person-centred, rights-based approach that extends beyond the prevention of maternal and perinatal morbidity and mortality to enhance women’s physical, psychological and sociocultural well-being, support healthy pregnancies, and improve the quality and utilization of antenatal care. Intended for policy-makers, programme managers and health professionals, the guideline informs the development of national policies, clinical protocols and service delivery models.\n\nDeveloped according to the WHO guideline development process, the document draws on systematic reviews and applies the GRADE and GRADE-CERQual approaches together with the DECIDE evidence-to-decision framework. It contains 49 recommendations covering nutritional interventions, maternal and fetal assessment, preventive measures, management of common physiological symptoms, and health system interventions to improve antenatal care utilization and quality. The guideline also introduces the 2016 WHO antenatal care model, recommending a minimum of eight contacts during pregnancy, and emphasizes implementation, dissemination and periodic updating as new evidence becomes available."
  },
  {
    "id": "9789241513111-eng",
    "type": "book",
    "title": "National health workforce accounts: a handbook",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          10,
          26
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241513111",
    "URL": "https://iris.who.int/handle/10665/259360",
    "language": "en",
    "abstract": "This handbook introduces the National Health Workforce Accounts (NHWA), a standardized framework developed by the World Health Organization to strengthen health workforce information systems and support evidence-based workforce planning and policy-making. The publication is intended to assist countries in monitoring and analysing health workforce capacity, distribution, education, labour market dynamics, financing, governance and information systems in the context of universal health coverage and the health-related Sustainable Development Goals. It outlines the rationale for improved health workforce data and highlights the role of harmonized metrics in addressing challenges related to workforce availability, accessibility, performance and retention.\n\nThe handbook presents a modular framework comprising 78 core indicators organized across 10 modules covering active workforce stock, education and training, regulation and accreditation, education financing, labour market flows, employment conditions, workforce spending and remuneration, skill mix, governance, and health workforce information systems. For each indicator, it provides definitions, methodological guidance, reporting requirements, data sources and disaggregation options. The publication also describes implementation principles, reporting standards and potential applications of the NHWA, supporting countries in strengthening health workforce monitoring, facilitating international comparability and informing policies aimed at improving health system performance and population access to quality health services."
  },
  {
    "id": "who-his-hwf-nhwa-20171-eng",
    "type": "report",
    "title": "Understanding national health workforce accounts",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/275758",
    "language": "en",
    "abstract": "Understanding National Health Workforce Accounts (NHWA) is an introductory guidance document developed by the World Health Organization to explain the purpose, policy relevance and structure of the National Health Workforce Accounts framework. The publication outlines how NHWA supports the standardization of health workforce information systems, improves the quality and comparability of data, and strengthens the evidence base for health workforce policy, planning and monitoring. Positioned within the context of universal health coverage, the Sustainable Development Goals, the Global Strategy on Human Resources for Health: Workforce 2030, and related international commitments, the document highlights the importance of reliable workforce information for addressing current and future health system challenges.\n\nThe publication describes the benefits of NHWA at national, regional and global levels and presents key policy questions that can be informed through systematic workforce data collection and analysis. It introduces the health labour market framework used by NHWA, emphasizing workforce production, labour market flows, distribution, productivity and regulation. The document also summarizes the development process of the NHWA indicators and explains the modular structure of the framework, which comprises ten modules covering workforce stock, education, labour market dynamics, employment conditions, financing, governance, planning and information systems. Together, these elements provide a foundation for evidence-informed decision-making and strengthened health workforce monitoring."
  },
  {
    "id": "10665-258516",
    "type": "report",
    "title": "WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 10: testing providers",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7,
          20
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/258516",
    "language": "en"
  },
  {
    "id": "10665-258517",
    "type": "report",
    "title": "WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 3: counsellors",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7,
          20
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/258517",
    "language": "en"
  },
  {
    "id": "10665-259268",
    "type": "report",
    "title": "WHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          10,
          17
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/259268",
    "language": "en",
    "abstract": "This publication compiles WHO recommendations on maternal health that have been approved by the WHO Guidelines Review Committee into a single, accessible reference for WHO staff, policy-makers, programme managers and health professionals. It brings together current WHO guidance covering the continuum of maternal care during pregnancy, childbirth and the postnatal period, with the dual purpose of facilitating access to recommendations and helping identify areas where further guideline updates are needed. The document indicates newly issued and updated recommendations since 2013 and provides, for each recommendation, its strength, the quality of supporting evidence and the corresponding source guideline.\n\nThe compilation addresses interventions to promote, prevent and protect maternal and perinatal health, including antenatal care, prevention and management of pre-eclampsia, preterm birth, peripartum infections, labour and childbirth, postpartum haemorrhage, postnatal care and health promotion, as well as the management of maternal conditions such as HIV infection, malaria and tuberculosis. Developed according to WHO’s guideline development process using the GRADE approach and structured evidence-to-decision frameworks, it presents evidence-informed recommendations intended to support consistent policy development, clinical practice and programme implementation across diverse health-care settings."
  },
  {
    "id": "10665-255866",
    "type": "report",
    "title": "WHO technical brief: preventing HIV during pregnancy and breastfeeding in the context of PrEP",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7,
          12
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/255866",
    "language": "en"
  },
  {
    "id": "who-rhr-1806-eng",
    "type": "report",
    "title": "Classification of digital health interventions v1.0: a shared language to describe the uses of digital technology for health",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          3,
          14
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/260480",
    "language": "en",
    "abstract": "This publication presents version 1.0 of the World Health Organization’s Classification of Digital Health Interventions (DHIs), a taxonomy developed to provide a shared and standardized language for describing how digital and mobile technologies are used to address health system needs. Intended primarily for public health audiences, the framework supports communication among policymakers, programme planners, implementers, researchers, donors and technology specialists by defining digital health interventions as discrete digital functionalities linked to specific health objectives. The classification was developed to facilitate evidence synthesis, landscape analyses, planning processes and the articulation of digital solutions to identified health system challenges.\n\nThe framework organizes digital health interventions into four primary groups according to the main user: clients, health-care providers, health system managers and data services. It links digital interventions to broader health system challenges and to system categories such as electronic medical records, logistics management information systems and telemedicine platforms. Developed through technical consultations, literature review and public feedback, the classification builds on existing mHealth and eHealth frameworks while providing a simplified and practical reference for health programmes. The document is intended to support the design, implementation, evaluation and interoperability of digital health initiatives and will be periodically updated to reflect emerging technologies and evolving practices in digital health."
  },
  {
    "id": "10665-273155",
    "type": "report",
    "title": "HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          7,
          18
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/273155",
    "language": "en"
  },
  {
    "id": "9789241514446-eng",
    "type": "book",
    "title": "National health workforce accounts: implementation guide",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          10,
          19
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241514446",
    "URL": "https://iris.who.int/handle/10665/275473",
    "language": "en",
    "abstract": "The National Health Workforce Accounts (NHWA) Implementation Guide provides practical guidance for countries on establishing and sustaining systems to collect, analyse, use and report standardized health workforce data. Developed as a companion document to the NHWA Handbook and in support of the Global Strategy on Human Resources for Health: Workforce 2030, the guide outlines a structured approach to strengthening health workforce information systems and improving the availability, quality and use of human resources for health data. It is intended for policy-makers, programme managers, technical experts and stakeholders involved in health workforce planning, monitoring and governance, and emphasizes collaboration across sectors such as health, education, labour, finance and statistics.\n\nThe guide presents an implementation framework organized into three phases—conceptualization, operationalization, and scaling up and sustainability—comprising eight steps that address political commitment, governance arrangements, planning, legal considerations, data compilation and analysis, validation, dissemination, and process review. It describes the roles of national institutions and multistakeholder coordination mechanisms, provides guidance on data quality, reporting and communication processes, and promotes the integration of existing information systems. By supporting the systematic monitoring of health workforce indicators, the guide aims to strengthen evidence-informed decision-making and contribute to health workforce development, universal health coverage and broader national and global health objectives."
  },
  {
    "id": "10665-274277",
    "type": "book",
    "title": "WHO recommendations on home-based records for maternal, newborn and child health",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          8,
          27
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241550352",
    "URL": "https://iris.who.int/handle/10665/274277",
    "language": "en",
    "abstract": "This WHO guideline provides evidence-based recommendations on the use of home-based records for maternal, newborn and child health (MNCH). Home-based records, whether paper or electronic, are household-held documents that complement facility-based records by documenting health services received and supporting continuity of care. Developed through the WHO guideline development process using systematic reviews, GRADE and GRADE-CERQual approaches, the guideline evaluates the effects of home-based records on MNCH outcomes, health service delivery, acceptability, feasibility and equity, addressing an important evidence gap despite their widespread use in at least 163 countries.\n\nThe guideline recommends the use of home-based records alongside facility-based records for pregnant women, mothers, newborns and children to improve care-seeking behaviours, household support and male involvement, maternal and child home care practices, infant and child feeding, and communication between health providers and women or caregivers. It concludes that current evidence is insufficient to identify a superior record type, format or design, and advises policy-makers to engage stakeholders when determining record content and implementation. The publication also discusses implementation considerations, highlights privacy and sustainability issues, identifies research gaps, and outlines priorities for future evidence generation and guideline updates."
  },
  {
    "id": "10665-325892",
    "type": "report",
    "title": "Policy brief: update of recommendations on first- and second-line antiretroviral regimens",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          7,
          17
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/325892",
    "language": "en"
  },
  {
    "id": "9789241515610-eng",
    "type": "book",
    "title": "Protecting all against tetanus: guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          11,
          8
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241515610",
    "URL": "https://iris.who.int/handle/10665/329882",
    "language": "en"
  },
  {
    "id": "10665-324745",
    "type": "report",
    "title": "Technical update: considerations for developing a monitoring and evaluation framework for viral load testing: collecting and using data for scale-up and outcomes",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          5,
          16
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/324745",
    "language": "en"
  },
  {
    "id": "10665-311941",
    "type": "book",
    "title": "WHO guideline: recommendations on digital interventions for health system strengthening",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          4,
          16
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241550505",
    "URL": "https://iris.who.int/handle/10665/311941",
    "language": "en",
    "abstract": "This WHO guideline provides evidence-based recommendations on the use of digital interventions to strengthen health systems and support progress towards universal health coverage (UHC). Developed in response to the growing adoption of digital technologies and the 2018 World Health Assembly resolution on digital health, it addresses the need for rigorous evaluation of digital health interventions to ensure that investments are informed by evidence of their benefits, harms, acceptability, feasibility, resource implications and equity considerations. The guideline emphasizes that digital technologies should complement, rather than replace, the fundamental components of well-functioning health systems.\n\nThe recommendations focus on a prioritized set of digital health interventions accessible at a minimum through mobile devices, including birth and death notification, stock notification and commodity management, client-to-provider and provider-to-provider telemedicine, targeted client communication, digital tracking of clients’ health status and services, health worker decision support, and digital learning for health workers. The guideline also outlines implementation considerations, identifies research gaps, and supports ministries of health, public health practitioners, development partners and other stakeholders in making evidence-based decisions on the adoption, scale-up and institutionalization of effective digital health interventions."
  },
  {
    "id": "10665-329964",
    "type": "report",
    "title": "WHO recommends social network-based HIV testing approaches for key populations as part of partner services package: policy brief",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          11,
          22
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/329964",
    "language": "en"
  },
  {
    "id": "9789241550581-eng",
    "type": "book",
    "title": "Consolidated guidelines on HIV testing services, 2019",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          11,
          3
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789241550581 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/336323",
    "language": "en",
    "abstract": "This guideline provides comprehensive, evidence-based recommendations to support countries in delivering high-quality, person-centred HIV testing services (HTS) across diverse populations and settings. Updating and consolidating previous WHO guidance issued in 2015 and 2016, it incorporates new evidence on HIV self-testing, social network-based HIV testing approaches, western blotting, and strategic service delivery to strengthen progress towards global HIV targets. Developed using the GRADE methodology and informed by systematic reviews, modelling studies and expert consultation, the guideline aims to improve the effectiveness, efficiency and quality of HIV testing while promoting timely linkage to prevention, treatment and care.\n\nThe publication addresses the full continuum of HIV testing services, including demand creation, pre- and post-test services, facility- and community-based testing, implementation considerations for priority populations, strategic planning, diagnostic testing strategies, quality assurance and programme monitoring. It provides updated recommendations on HIV self-testing, provider-assisted referral, social network-based approaches and the use of dual HIV/syphilis rapid diagnostic tests, while emphasizing the WHO 5Cs of HIV testing services: consent, confidentiality, counselling, correct results and connection. Intended for policy-makers, national programme managers, health-care providers and implementing partners, the guideline supports the expansion of equitable, evidence-informed HIV testing services to improve diagnosis and strengthen national HIV responses."
  },
  {
    "id": "9789240010567-eng",
    "type": "book",
    "title": "Digital implementation investment guide (DIIG): integrating digital interventions into health programmes",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          9,
          15
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240010567 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/334306",
    "language": "en"
  },
  {
    "id": "10665-332907",
    "type": "book",
    "title": "Package of care for children and adolescents with advanced HIV disease: stop AIDS: technical brief",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7,
          1
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240008045 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/332907",
    "language": "en"
  },
  {
    "id": "10665-331170",
    "type": "book",
    "title": "WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          25
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240001503",
    "URL": "https://iris.who.int/handle/10665/331170",
    "language": "en",
    "abstract": "This guideline provides updated WHO recommendations for the programmatic management of tuberculosis preventive treatment (TPT) as part of the WHO consolidated guidelines on tuberculosis. It focuses on the prevention of active tuberculosis among people at increased risk of disease progression, particularly people living with HIV, household contacts of patients with tuberculosis and other vulnerable population groups. The document incorporates new evidence on shorter rifamycin-containing preventive treatment regimens and updates previous WHO guidance to improve the clarity, consistency and global applicability of recommendations.\n\nDeveloped in accordance with WHO Guideline Review Committee requirements, the publication presents 18 evidence-based recommendations covering the identification of populations eligible for preventive treatment, exclusion of active tuberculosis, testing for latent tuberculosis infection, recommended preventive treatment regimens, monitoring and evaluation, and implementation considerations. Recommendations were formulated using the GRADE approach, taking into account the certainty of evidence, effectiveness, safety, values and preferences, equity, resource implications, acceptability and feasibility. The guideline is intended to support national policy-makers, programme managers and health-care providers in strengthening tuberculosis prevention and advancing implementation of the WHO End TB Strategy."
  },
  {
    "id": "10665-331525",
    "type": "book",
    "title": "WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          23
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240002906",
    "URL": "https://iris.who.int/handle/10665/331525",
    "language": "en",
    "abstract": "This operational handbook provides practical guidance for the programmatic management and scale-up of tuberculosis preventive treatment (TPT) in line with WHO consolidated guidelines on tuberculosis. The publication addresses the global burden of tuberculosis infection and the need to expand preventive interventions among populations at high risk of developing TB disease, particularly people living with HIV, household contacts of TB patients and other vulnerable groups. It supports implementation of commitments made at the United Nations High-Level Meeting on Tuberculosis and outlines strategies to strengthen national responses through integrated, people-centred approaches.\n\nThe handbook describes the cascade of care for TPT, including identification of target populations, exclusion of active TB disease, testing for TB infection, treatment options, management of adverse events, adherence support, monitoring and evaluation, and ethical considerations. It also provides operational guidance for contact investigation, integration of preventive services with active TB case finding and HIV services, health system strengthening, and resource mobilization. Practical implementation tools, policy considerations and monitoring indicators are included to assist national TB programmes, policy-makers and health-care providers in adapting and scaling up TPT services in diverse epidemiological and health system settings."
  },
  {
    "id": "10665-350214",
    "type": "book",
    "title": "Comprehensive package of care for infants and young children exposed to HIV: policy brief",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          12,
          9
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240040236 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/350214",
    "language": "en"
  },
  {
    "id": "9789240031593-eng",
    "type": "book",
    "title": "Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          16
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240031593 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/342899",
    "language": "en",
    "abstract": "These consolidated guidelines provide comprehensive, evidence-based recommendations for HIV prevention, testing, treatment, service delivery and programme monitoring across the continuum of HIV care. Updating the 2016 WHO consolidated guidelines, this edition integrates guidance issued between 2016 and 2021 and reflects major advances in clinical practice, diagnostics and service delivery. Developed using the GRADE approach and informed by expert consultation and country experience, the guidelines aim to support countries in implementing high-quality, person-centred HIV services while advancing universal health coverage and progress towards ending AIDS as a public health threat by 2030.\n\nThe publication addresses HIV testing strategies, prevention interventions, antiretroviral therapy, management of advanced HIV disease, care for common coinfections and comorbidities, differentiated service delivery, procurement, laboratory services and programme monitoring. It incorporates updated recommendations on HIV self-testing, pre-exposure and post-exposure prophylaxis, dolutegravir-based treatment, rapid antiretroviral therapy initiation, viral load monitoring and community-based models of care. Intended primarily for national HIV programme managers, policy-makers and health-care providers, the guidelines also serve as a resource for technical partners, community organizations and people living with HIV to support the implementation of effective, equitable and people-centred HIV programmes."
  },
  {
    "id": "10665-342236",
    "type": "report",
    "title": "Contingency fund for emergencies: 2020 annual report",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          2
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/342236",
    "language": "en",
    "abstract": "This annual report presents an overview of the activities, financing and operational impact of the World Health Organization’s Contingency Fund for Emergencies (CFE) in 2020. The publication describes how the CFE enabled WHO to respond rapidly to 14 emergencies in 13 countries and to support the global response to COVID-19 through the release of nearly US$ 44 million. It outlines the Fund’s role in supporting outbreak control, emergency health operations, supply chain management, surveillance, vaccination activities, procurement of essential medical supplies and continuity of health services during infectious disease outbreaks, humanitarian crises, natural disasters and technological emergencies.\n\nThe report highlights WHO-supported responses to the COVID-19 pandemic, Ebola outbreaks in the Democratic Republic of the Congo, the Beirut port explosion, Tropical Cyclone Harold in Vanuatu and the humanitarian crisis in north-eastern Syria. It also examines funding allocations, reimbursement mechanisms, donor contributions and accountability arrangements governing the CFE. Through operational examples and financial analysis, the publication demonstrates the importance of rapid, flexible and predictable financing for strengthening emergency preparedness and enabling timely public health action in complex and evolving emergencies."
  },
  {
    "id": "10665-339745",
    "type": "book",
    "title": "Digital adaptation kit for antenatal care: operational requirements for implementing WHO recommendations in digital systems",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          2,
          18
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240020306 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/339745",
    "language": "en"
  },
  {
    "id": "10665-341997",
    "type": "book",
    "title": "Digital adaptation kit: family planning: operational requirements for implementing WHO recommendations in digital systems",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          6,
          25
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240029743 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/341997",
    "language": "en"
  },
  {
    "id": "WHO-2019-nCoV-Digital-certificates-vaccination-2021.1-eng",
    "type": "report",
    "title": "Digital documentation of COVID-19 certificates: vaccination status: technical specifications and implementation guidance, 27 August 2021",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          28
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/343361",
    "language": "en"
  },
  {
    "id": "10665-349550",
    "type": "book",
    "title": "Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          11,
          25
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240039360 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/349550",
    "language": "en",
    "abstract": "This guidance document provides updated World Health Organization criteria and processes for validating the elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and hepatitis B virus (HBV) as public health priorities. Building on previous editions focused on HIV and syphilis, this third version incorporates validation guidance for HBV within the framework of the Triple Elimination Initiative. The document outlines standardized indicators, targets and assessment procedures for evaluating progress towards EMTCT across diverse epidemiological and programmatic settings. It addresses impact and process indicators, surveillance and laboratory quality standards, programme assessment, and requirements related to human rights, gender equality and community engagement.\n\nThe document emphasizes integrated maternal and child health approaches, universal access to quality antenatal and prevention services, and the importance of strong health systems and surveillance mechanisms. It also provides guidance for countries with high disease burdens through the Path to Elimination framework, as well as for countries with small numbers of affected pregnant women and special populations. Intended for national, regional and global validation bodies, the document supports harmonized validation processes while allowing countries to pursue single, dual or triple EMTCT validation according to national readiness and regional priorities."
  },
  {
    "id": "10665-344249",
    "type": "book",
    "title": "Global strategy on digital health 2020-2025",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          8,
          18
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240020924 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/344249",
    "language": "en",
    "abstract": "The Global strategy on digital health 2020–2025 provides a framework to support Member States in strengthening health systems through the appropriate adoption and use of digital technologies. Developed in response to World Health Assembly mandates and aligned with the Sustainable Development Goals and WHO’s Triple Billion targets, the strategy outlines a shared vision for improving health and well-being through accessible, affordable, secure and sustainable digital health solutions. It emphasizes the importance of strong governance, interoperability, ethical use of data, privacy protection, workforce capacity-building and investment in digital infrastructure to support national health priorities and universal health coverage.\n\nThe document establishes four strategic objectives: promoting global collaboration and knowledge exchange; advancing the implementation of national digital health strategies; strengthening governance for digital health at global, regional and national levels; and advocating people-centred health systems enabled by digital technologies. It also presents guiding principles, an implementation framework and monitoring mechanisms to support countries in developing interoperable digital health ecosystems. Particular attention is given to addressing barriers faced by low- and middle-income countries and ensuring that digital transformation contributes to equitable, effective and resilient health systems."
  },
  {
    "id": "10665-340190",
    "type": "book",
    "title": "Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3,
          17
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240022232 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/340190",
    "language": "en",
    "abstract": "This guideline presents updated WHO recommendations on selected priority areas across the HIV prevention, diagnosis and treatment continuum, developed in response to emerging evidence, implementation experience and evolving clinical practice. Prepared according to WHO Guideline Review Committee procedures and informed by systematic reviews using the GRADE approach, it updates and complements the 2016 consolidated HIV guidelines. The publication addresses key public health challenges affecting the global HIV response, particularly in resource-limited settings, and supports progress towards ending AIDS as a public health threat by 2030 through a public health approach to service delivery.\n\nThe guideline introduces or updates recommendations on the use of the dapivirine vaginal ring as an additional HIV prevention option for women at substantial risk of infection, point-of-care technologies for infant HIV diagnosis and viral load monitoring, revised treatment monitoring algorithms, and earlier initiation of antiretroviral therapy for people living with HIV and tuberculosis. It also provides updated clinical considerations for rapid antiretroviral therapy initiation and outlines implementation principles to support national adaptation. Intended for policy-makers, programme managers, clinicians and implementing partners, the guideline aims to strengthen evidence-based HIV prevention, diagnosis, treatment monitoring and care across diverse settings."
  },
  {
    "id": "9789240016514-eng",
    "type": "book",
    "title": "Leave no one behind: guidance for planning and implementing catch-up vaccination",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          4,
          13
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240016514 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/340749",
    "language": "en"
  },
  {
    "id": "10665-349570",
    "type": "report",
    "title": "Sexual and reproductive health and rights: infographic snapshot: Kuwait 2021",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          11,
          25
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/349570",
    "language": "en"
  },
  {
    "id": "10665-349683",
    "type": "report",
    "title": "Sexual and reproductive health and rights: infographic snapshot: North Macedonia 2021",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          11,
          29
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/349683",
    "language": "en"
  },
  {
    "id": "10665-340255",
    "type": "book",
    "title": "WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          3,
          22
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240022676 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/340255",
    "language": "en",
    "abstract": "Tuberculosis remains one of the leading causes of death from a single infectious agent despite being largely preventable and curable. This updated WHO guideline provides evidence-based recommendations on systematic screening for tuberculosis disease to support earlier diagnosis, timely initiation of treatment and reduced transmission. It revises the 2013 guidance in light of new evidence on the effectiveness of screening interventions and the performance of screening tools, using the GRADE approach to assess the certainty of evidence and the strength of recommendations. The document is intended to assist countries in planning and implementing screening strategies adapted to their epidemiological and health system contexts.\n\nThe guideline presents recommendations for systematic screening in the general population and in groups at increased risk of tuberculosis, including people living with HIV, household contacts, prisoners, miners, migrants and other vulnerable populations. It also reviews the use of symptom screening, chest radiography, computer-aided detection software, C-reactive protein and molecular WHO-recommended rapid diagnostic tests as screening tools, together with guidance on monitoring, evaluation and implementation considerations. The publication identifies research gaps and is accompanied by an operational handbook providing practical guidance for applying the recommendations in national tuberculosis programmes."
  },
  {
    "id": "10665-342365",
    "type": "book",
    "title": "WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          6
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240030824 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/342365",
    "language": "en",
    "abstract": "This second edition of the WHO guideline provides updated evidence-based recommendations for screening and treatment of cervical pre-cancer lesions to prevent cervical cancer in both the general population of women and women living with HIV. Developed in support of the WHO global strategy to eliminate cervical cancer as a public health problem, the guideline responds to advances in screening technologies and implementation approaches by updating previous recommendations and introducing new guidance to simplify clinical algorithms while improving feasibility, acceptability and programme performance across diverse health system settings. The recommendations were developed in accordance with WHO guideline development procedures using systematic reviews, mathematical modelling where necessary, GRADE assessments of the certainty of evidence, evidence-to-decision frameworks, and consideration of feasibility, costs, acceptability and users’ values and preferences.\n\nThe guideline presents recommendations and good practice statements on primary screening tests, screening intervals, age at initiation and cessation of screening, triage strategies, follow-up after positive screening results, treatment approaches, and programme implementation for both population groups. It addresses service delivery, integration with HIV care, implementation considerations, research gaps and dissemination, while emphasizing the transition to HPV DNA testing, the use of evidence-based screening and treatment algorithms, and country adaptation according to available resources and local context to improve coverage, quality of care and cervical cancer prevention."
  },
  {
    "id": "10665-360601",
    "type": "book",
    "title": "Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          7,
          22
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240052390 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/360601",
    "language": "en",
    "abstract": "This guideline provides consolidated, evidence-based recommendations for the prevention, diagnosis, treatment and care of HIV, viral hepatitis and sexually transmitted infections (STIs) among key populations. It responds to the disproportionate burden of these infections in groups such as men who have sex with men, sex workers, people who inject drugs, people in prisons and other closed settings, and trans and gender diverse individuals, and to the structural barriers that limit their access to health services. The document aims to support countries in strengthening integrated, people-centred responses to these interconnected epidemics.\n\nDeveloped using WHO guideline standards and the GRADE methodology, the publication brings together existing and new recommendations and organizes them into comprehensive packages of interventions. It addresses enabling factors such as legal and policy environments, stigma, discrimination, violence and community empowerment, alongside essential health interventions including prevention, testing, treatment and harm reduction. The guideline also outlines service delivery approaches, such as community-led services, integration and decentralization, and provides guidance for programme planning, implementation and monitoring. Intended for policy-makers, programme managers and health-care providers, it supports the prioritization of effective, context-appropriate strategies to improve access, coverage and health outcomes for key populations."
  },
  {
    "id": "10665-360948",
    "type": "book",
    "title": "Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          7,
          28
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240055315 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/360948",
    "language": "en",
    "abstract": "These consolidated guidelines provide normative guidance for strengthening HIV strategic information through person-centred routine data systems that support both clinical care and programme management. Developed in response to persistent gaps in HIV prevention, testing, treatment and retention despite substantial progress in the global HIV response, the guidelines promote the collection and use of individual-level longitudinal data to improve continuity of care, strengthen linkage across services and enhance monitoring of programme performance. They consolidate and update previous WHO guidance while introducing recommendations on person-centred monitoring, digital health information systems, interoperability, data quality, surveillance and the integration of HIV services with tuberculosis, viral hepatitis, sexually transmitted infections and other related conditions.\n\nThe publication outlines recommendations and operational guidance on HIV prevention monitoring, patient monitoring, surveillance, digital health data, routine data use, priority indicators and implementation considerations. It emphasizes the transition from aggregate reporting to person-centred, digital information systems that support clinical decision-making, programme improvement and public health action while ensuring data privacy, confidentiality and security. The guidelines also describe minimum datasets, standardized monitoring tools and approaches to improving data quality and using routine information to strengthen service delivery and measure progress towards global HIV targets."
  },
  {
    "id": "10665-360861",
    "type": "book",
    "title": "Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance: technical brief",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          7,
          27
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240053694 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/360861",
    "language": "en"
  },
  {
    "id": "10665-357088",
    "type": "book",
    "title": "Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          6,
          23
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240052178 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/357088",
    "language": "en",
    "abstract": "This guideline provides updated, evidence-informed recommendations for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Developed in accordance with WHO Guideline Review Committee procedures, it replaces the 2018 guidance and incorporates important new evidence published in 2021 on the preferred antifungal induction regimen for cryptococcal meningitis. The recommendations are based on systematic reviews using the GRADE approach and are supported by considerations of acceptability, values and preferences, feasibility and cost–effectiveness. The document addresses cryptococcal disease as a major opportunistic infection contributing substantially to HIV-related illness, disability and mortality, particularly in low- and middle-income countries, and identifies priority knowledge gaps to inform future research.\n\nThe guideline recommends updated approaches to the diagnosis, prevention and treatment of cryptococcal disease, including revised guidance on induction therapy for cryptococcal meningitis, while maintaining earlier recommendations where evidence remains unchanged. It also outlines principles for implementation within a public health approach and is intended to support HIV programme managers, policy-makers, health-care professionals and people living with HIV in improving the prevention, early diagnosis and clinical management of cryptococcal disease."
  },
  {
    "id": "10665-360869",
    "type": "book",
    "title": "Guidelines on long-acting injectable cabotegravir for HIV prevention",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          7,
          27
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240054097 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/360869",
    "language": "en",
    "abstract": "This guideline provides evidence-informed recommendations on the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention in people at substantial risk of HIV infection. Developed according to WHO guideline development procedures, it is based on systematic reviews, GRADE assessments and additional evidence on effectiveness, safety, acceptability, feasibility, equity and cost–effectiveness. The document reviews the global HIV prevention context, the rationale for expanding HIV prevention choices, and the evidence supporting CAB-LA as an additional PrEP option. It also outlines the principles guiding implementation within a public health and human rights framework and identifies the intended audiences for the recommendations.\n\nThe guideline recommends that long-acting injectable cabotegravir may be offered as an additional HIV prevention choice as part of combination prevention approaches for people at substantial risk of HIV infection. It discusses key implementation considerations, including HIV testing, service delivery models, comprehensive prevention services, community engagement, provider training and adherence support. The publication also identifies priority research gaps related to safety, drug resistance, delivery strategies and population-level impact, and describes the guideline development process, dissemination strategy and supporting evidence underpinning the recommendation."
  },
  {
    "id": "10665-352522",
    "type": "book",
    "title": "WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          3,
          18
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240046764 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/352522",
    "language": "en",
    "abstract": "Tuberculosis (TB) remains a major cause of morbidity and mortality among children and adolescents, with substantial gaps in case detection, diagnosis and access to preventive treatment worldwide. This guideline consolidates new and existing WHO recommendations for the management of TB in these populations, replacing the 2014 guidance and reflecting the latest evidence on prevention, screening, diagnosis, treatment and models of care. It aims to support countries in strengthening the continuum of TB care and improving health outcomes through evidence-based policies and practices tailored to the specific needs of children, adolescents and their families.\n\nThe publication provides recommendations on TB screening and contact investigation, TB preventive treatment, diagnostic approaches, treatment of drug-susceptible and drug-resistant TB, management of TB meningitis, and decentralized, family-centred models of care. It incorporates updated evidence on the use of Xpert MTB/RIF Ultra, integrated treatment decision algorithms, shortened treatment regimens for non-severe TB, and therapeutic options for multidrug- or rifampicin-resistant disease in children. Developed according to WHO guideline development standards, the document is intended for national TB programmes, policy-makers, health professionals and implementing partners, and contributes to global efforts to reduce TB-related morbidity and mortality in line with the End TB Strategy and Sustainable Development Goals."
  },
  {
    "id": "10665-362227",
    "type": "book",
    "title": "WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 13: integrating STI services",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          9,
          5
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240057425 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/362227",
    "language": "en",
    "abstract": "This module of the WHO Implementation Tool for Pre-Exposure Prophylaxis (PrEP) of HIV Infection provides operational guidance on integrating sexually transmitted infection (STI) services into HIV PrEP programmes. Developed for programme managers, decision-makers, facility managers and health-care workers, it compiles existing WHO recommendations and evidence to support the planning, implementation and scale-up of integrated, people-centred sexual health services. The document outlines the epidemiology and burden of STIs, particularly among populations who may benefit from or use PrEP, and highlights the public health rationale for strengthening STI prevention, testing, treatment and follow-up within PrEP delivery platforms.\n\nThe module describes practical approaches to integrating STI services across different service delivery models, including considerations related to workforce capacity, task sharing, monitoring, financing and demand generation. It presents guidance on counselling, health promotion, screening, diagnostic testing, partner services, clinical management, referral pathways and prevention measures such as condom provision and vaccination. Emphasizing differentiated service delivery and human rights principles, the publication aims to improve access to comprehensive sexual health care, enhance service quality and support efforts to reduce the burden of HIV and other sexually transmitted infections through coordinated and efficient health-system responses."
  },
  {
    "id": "10665-352523",
    "type": "book",
    "title": "WHO operational handbook on tuberculosis: module 5: management of tuberculosis in children and adolescents",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          3,
          18
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240046832 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/352523",
    "language": "en",
    "abstract": "This operational handbook provides practical guidance for implementing World Health Organization recommendations on the prevention, screening, diagnosis and management of tuberculosis (TB) in children and adolescents under programmatic conditions and across different levels of the health system. Developed alongside the WHO consolidated guidelines on tuberculosis, the publication addresses the specific epidemiological, clinical and psychosocial vulnerabilities of children and adolescents affected by TB, including challenges related to diagnosis, treatment adherence, prevention and continuity of care. The handbook aims to support the development and revision of national policies, operational guidance and service delivery approaches tailored to the needs of these populations.\n\nThe handbook covers the full continuum of TB care, including contact investigation, systematic screening, preventive treatment, diagnostic approaches for pulmonary and extrapulmonary TB, and treatment of drug-susceptible and drug-resistant disease. It also addresses decentralized and family-centred models of care, management of TB in children and adolescents living with HIV, TB during pregnancy, malnutrition, pneumonia, adolescent health needs and palliative care. Practical tools, implementation guidance and standard operating procedures are included to support programme managers and health-care providers in strengthening child and adolescent TB services."
  },
  {
    "id": "9789240081949-eng",
    "type": "book",
    "title": "Classification of digital interventions, services and applications in health: a shared language to describe the uses of digital technology for health",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          10,
          24
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240081949 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/373581",
    "language": "en",
    "abstract": "This second edition of the Classification of Digital Interventions, Services and Applications in Health provides a standardized taxonomy for describing how digital technologies are used to address individual and health system needs. Developed by WHO, the classification establishes a shared language to support communication among policy-makers, health programme managers, researchers, implementers, technology developers and other stakeholders involved in digital health. It organizes digital health interventions around discrete technological capabilities designed to address health system challenges and links these interventions to the digital services and application types through which they are delivered.\n\nThe publication updates and expands the first edition published in 2018 to reflect advances in digital health technologies, evolving implementation practices and lessons learned from global use. The framework is structured around three interconnected axes: health system challenges, digital health interventions and digital services and application types. It includes interventions for persons, health-care providers, health system managers and data services, alongside categories of digital applications and information systems. The classification is intended to support planning, implementation, investment analysis, research, interoperability considerations, policy development and the governance of digital health initiatives, thereby facilitating more consistent and effective use of digital technologies in health systems."
  },
  {
    "id": "9789240085138-eng",
    "type": "book",
    "title": "Digital adaptation kit for HIV: operational requirements for implementing WHO recommendations in digital systems",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          12,
          21
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240085138 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/375230",
    "language": "en",
    "abstract": "This second edition of the digital adaptation kit for HIV provides operational, software-neutral requirements to support the incorporation of WHO clinical, public health and data use recommendations into digital systems. Developed within the SMART Guidelines approach, it focuses on the content requirements for person-centred digital tracking and decision support systems used by health workers for HIV services in primary health care settings. The kit is intended to facilitate transparent, consistent and adaptable translation of narrative guidance into digital implementations while supporting interoperability and local customization.\n\nThe publication organizes HIV-related requirements into eight components: health interventions and associated recommendations; generic personas; illustrative user scenarios; business processes and workflows; core data elements; decision support and scheduling logic; indicators and performance metrics; and high-level functional and non-functional requirements. It covers processes including HIV testing, pre-exposure prophylaxis, care and treatment, prevention of mother-to-child transmission, infant diagnosis, diagnostics, client follow-up, referral, and aggregate reporting and data use, with complementary operational resources provided in web annexes."
  },
  {
    "id": "10665-375056",
    "type": "report",
    "title": "Digital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex A: data dictionary",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          12,
          14
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/375056",
    "language": "en",
    "abstract": "This web annex provides the standardized data dictionary supporting the WHO Digital adaptation kit for HIV: operational requirements for implementing WHO recommendations in digital systems. It defines the core data elements required to implement WHO recommendations across HIV prevention, testing, treatment, care, diagnostics, referral, follow-up and reporting workflows in digital health systems. The annex specifies standardized data element names, definitions, data types, permissible values, calculated fields, coding structures and unique identifiers to support consistent data capture, interoperability and alignment with international terminology standards. Organized according to the business processes described in the digital adaptation kit, it also includes guidance on adapting the data dictionary to national programme requirements while preserving standardized information exchange. Intended for digital health architects, software developers, implementers and programme managers, this resource provides a practical foundation for configuring, customizing and maintaining interoperable HIV information systems that accurately reflect WHO recommendations."
  },
  {
    "id": "10665-375057",
    "type": "report",
    "title": "Digital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex B: decision-support logic",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          12,
          14
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/375057",
    "language": "en",
    "abstract": "This web annex provides the standardized decision-support logic supporting the WHO Digital adaptation kit for HIV: operational requirements for implementing WHO recommendations in digital systems. It translates WHO HIV recommendations into structured, software-neutral decision tables that can be incorporated into digital tracking and decision-support systems to support consistent clinical and public health decision-making. The annex includes decision logic for HIV testing, prevention, treatment, advanced HIV disease, prevention of mother-to-child transmission, diagnostics, follow-up and related service delivery workflows, using standardized input expressions, decision rules, outputs, scheduling logic and triggering events. It also provides implementation guidance on rule syntax, comparison operators, hit policies and coding conventions to promote transparency, interoperability and consistent interpretation across digital platforms. Intended for software developers, digital health architects, implementers and programme managers, this resource supports the development and adaptation of standards-based decision-support functionality that accurately reflects WHO recommendations while allowing contextualization for national policies and health system requirements."
  },
  {
    "id": "10665-375058",
    "type": "report",
    "title": "Digital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex C: indicators table",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          12,
          14
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/375058",
    "language": "en",
    "abstract": "This web annex provides the standardized indicators and performance metrics supporting the WHO Digital adaptation kit for HIV: operational requirements for implementing WHO recommendations in digital systems. It defines a comprehensive set of indicators for monitoring HIV prevention, testing, treatment, care, diagnostics and programme performance, translating WHO recommendations into standardized indicator specifications that can be incorporated into digital health systems. For each indicator, the annex documents indicator definitions, calculation methods, numerators and denominators, disaggregation variables, required data elements, reporting requirements, data sources, implementation notes and mappings to international monitoring frameworks, including WHO, UNAIDS, Global Fund and PEPFAR indicators where applicable. Intended for programme managers, monitoring and evaluation specialists, digital health architects and software developers, this resource supports the standardized measurement, reporting and analysis of HIV programme performance while promoting interoperability, consistent implementation of WHO recommendations and adaptation to national monitoring requirements."
  },
  {
    "id": "10665-375059",
    "type": "report",
    "title": "Digital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex D: function and non-functional requirements",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          12,
          14
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/375059",
    "language": "en",
    "abstract": "This web annex provides the high-level functional and non-functional requirements supporting the WHO Digital adaptation kit for HIV: operational requirements for implementing WHO recommendations in digital systems. It translates WHO HIV recommendations and service delivery workflows into standardized system requirements to guide the design, development, procurement and implementation of interoperable digital health solutions. The annex defines functional requirements for key business processes across HIV prevention, testing, treatment, care, diagnostics, referral, follow-up and reporting, together with non-functional requirements addressing system performance, security, confidentiality, privacy, interoperability, usability, reliability and offline functionality. Structured as a software-neutral implementation resource, it enables consistent interpretation of operational requirements while allowing adaptation to national policies and digital health architectures. Intended for digital health architects, software developers, implementers, procurers and programme managers, this resource supports the development of standards-based HIV information systems that accurately implement WHO recommendations while ensuring robust, secure and sustainable digital health solutions."
  },
  {
    "id": "9789240081291-eng",
    "type": "book",
    "title": "National health workforce accounts: a handbook",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          11,
          23
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240081291 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/374320",
    "language": "en",
    "abstract": "The National Health Workforce Accounts (NHWA) Handbook, second edition, provides the conceptual framework, standards, methods and indicators that support the systematic collection, analysis and use of health workforce data for evidence-informed policy-making and planning. Developed by the World Health Organization, the handbook supports implementation of the National Health Workforce Accounts as a country-led system to strengthen human resources for health information systems, improve data quality and availability, and monitor progress towards universal health coverage, the Sustainable Development Goals and other global health objectives. It describes the rationale, principles and applications of NHWA at national, regional and global levels and outlines a modular approach to health workforce monitoring.\n\nThe handbook presents guidance on implementation and reporting methods and defines a set of standardized indicators organized into four modules covering workforce stock and flows, education, finance and expenditures, and working conditions, governance and leadership. It explains indicator metadata, calculation methods, disaggregation requirements and reporting standards, and illustrates how NHWA data can be used to support workforce planning, policy development, retention strategies, equity analyses and monitoring of health workforce trends. The revised edition incorporates updated indicators, occupational classifications, tools and guidance to address evolving health workforce priorities and emerging global health challenges."
  },
  {
    "id": "10665-372197",
    "type": "book",
    "title": "Pandemic influenza preparedness framework: annual progress report, 1 January – 31 December 2022",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          8,
          4
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240076907 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/372197",
    "language": "en",
    "abstract": "The Pandemic Influenza Preparedness (PIP) Framework: annual progress report, 1 January–31 December 2022 presents technical and financial progress in implementing the PIP Framework, which aims to strengthen the sharing of influenza viruses with human pandemic potential and improve developing countries’ access to pandemic vaccines and other response supplies. The report assesses progress under the High-Level Implementation Plan II (2018–2023), including activities financed through the industry-funded Partnership Contribution mechanism.\n\nThe report documents achievements and challenges in influenza laboratory capacity and surveillance, virus sharing, disease burden estimation, regulatory preparedness, risk communication and community engagement, deployment planning, and national pandemic preparedness. In 2022, 91% of Partnership Contribution recipient countries reported influenza data to FluNet, 48 countries had implemented regulatory approaches for pandemic influenza products, and 37 countries had developed or updated pandemic preparedness plans. It also presents progress in securing pandemic response products through benefit-sharing agreements, alongside financial allocations, expenditures and implementation milestones."
  },
  {
    "id": "10665-371662",
    "type": "report",
    "title": "Poliovirus containment: guidance to minimize risk for facilities collecting, handling or storing materials potentially infectious for polioviruses: web annex A: country and area specific poliovirus data, April 2023 update",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          7,
          24
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/371662",
    "language": "en",
    "abstract": "This web annex provides updated country- and area-specific poliovirus circulation data to support the assessment of potentially infectious materials in facilities collecting, handling or storing samples that may contain polioviruses. It accompanies the second edition of Poliovirus containment: guidance to minimize risks for facilities collecting, handling or storing materials potentially infectious for polioviruses and is intended to assist facilities in identifying samples requiring appropriate risk mitigation or containment measures.\n\nThe annex presents Table A2.1, which compiles poliovirus circulation dates by country and area, including wild poliovirus (WPV), vaccine-derived poliovirus (VDPV) and oral polio vaccine type 2/novel oral polio vaccine type 2/Sabin2 potentially infectious material periods. The data were derived from national poliovirus reports, systematic literature searches and consultations with WHO regional offices, and are regularly revised and updated. The information supports the identification and management of potentially infectious materials according to the containment requirements outlined in the accompanying guidance."
  },
  {
    "id": "10665-369381",
    "type": "book",
    "title": "Toolkit for analysis and use of routine health facility data: integrated health services analysis: district and facility level",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2023,
          6,
          16
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240060609 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/369381",
    "language": "en",
    "abstract": "This guidance document, part of the WHO Toolkit for analysis and use of routine health facility data, provides practical guidance on the integrated analysis and use of routine health information system (RHIS) data at district and health facility levels. It is intended to support managers, analysts and other health system stakeholders in monitoring health service delivery and using routine data for operational decision-making. The document promotes an integrated, standards-based approach that uses a limited set of tracer indicators representing multiple programmes and service components, thereby supporting primary health care, universal health coverage and the health-related Sustainable Development Goals.\n\nThe publication presents principles for RHIS data analysis, including integration across programmes, focused use of key indicators, standardization of analyses and visualizations, routine assessment of data quality, and purpose-oriented use of information for management and planning. It organizes indicators into three groups: health status and epidemiological profile, health service performance, and health service resources. For each group, the publication provides indicator definitions, metadata, recommended disaggregations, analytical approaches, and examples of dashboards and visualizations. It emphasizes the interpretation of routine data within local contexts and illustrates how standardized dashboards can support supervision, performance review, resource allocation and continuous improvement of health services at subnational levels."
  },
  {
    "id": "9789240099456-eng",
    "type": "book",
    "title": "Digital adaptation kit for immunizations: operational requirements for implementing WHO recommendations in digital systems",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2024,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240099456 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/380303",
    "language": "en",
    "abstract": "This publication presents the World Health Organization’s digital adaptation kit (DAK) for immunizations, developed within the SMART Guidelines framework to support the implementation of WHO immunization recommendations in digital systems. The document provides operational and software-neutral specifications intended to facilitate the translation of immunization guidance into interoperable digital health applications, particularly person-centred point-of-service systems and electronic immunization registries. It outlines the role of digital adaptation kits in strengthening digital health systems by improving the consistency, transparency and standardization of health content, workflows, data structures and decision-support logic used in immunization programmes. The publication also situates the DAK within broader digital health strategies and interoperability standards.\n\nThe document describes eight core components of the immunization DAK, including health interventions and recommendations, generic personas, user scenarios, workflows, core data elements, decision-support logic, indicators and functional requirements. It incorporates WHO guidance related to routine immunization, electronic immunization registries and digital health interventions, while emphasizing adaptability to country-specific policies and implementation contexts. Additional sections address interoperability, data standards, workflow optimization and the use of digital systems to support longitudinal tracking, reporting, decision support and communication within immunization services. The publication is intended for immunization programme managers, digital health teams, software developers and implementers involved in designing and deploying digital immunization systems."
  },
  {
    "id": "9789240101197-eng",
    "type": "book",
    "title": "Digital transformation handbook for health supply chain architecture",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2024,
          11,
          11
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240101197 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/379506",
    "language": "en",
    "abstract": "This handbook provides practical guidance for countries seeking to digitally transform public health supply chains through the development of coherent strategies, interoperable architectures and sustainable implementation approaches. Developed within the WHO SMART Guidelines framework, it addresses the growing need for integrated digital ecosystems that support forecasting, procurement, warehousing, distribution, dispensing and traceability of health products. The publication outlines the role of digital technologies in improving efficiency, data availability, interoperability and decision-making across supply chain processes, while helping ensure timely access to quality-assured medicines and health products.\n\nThe publication presents a stepwise approach for defining a digital health supply chain (DHSC) strategy, assessing existing health supply chain information systems, designing a target architecture, planning implementation and supporting product traceability. It emphasizes stakeholder engagement, alignment with national health, digital health and supply chain strategies, use of open standards, and long-term scalability and sustainability. Drawing on country experiences and established digital health frameworks, the handbook offers practical tools, templates and examples to support governance, planning and coordination of digital transformation initiatives, with the aim of strengthening supply chain performance, improving visibility across the supply chain and enhancing patient safety."
  },
  {
    "id": "9789240093362-eng",
    "type": "book",
    "title": "Digital transformation handbook for primary health care: optimizing person-centred point of service systems",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2024,
          11,
          4
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240093362 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/379452",
    "language": "en",
    "abstract": "This handbook provides practical guidance for countries seeking to digitally transform primary health care through the development and implementation of person-centred point of service systems (PCPOSS). It addresses the transition from paper-based and fragmented digital systems towards integrated, interoperable digital solutions that support service delivery, continuity of care, data use and health system strengthening. Grounded in WHO recommendations on digital interventions for health system strengthening and aligned with the SMART Guidelines framework, the publication outlines approaches for translating clinical and public health guidance into digital systems while maintaining fidelity to normative standards.\n\nThe publication presents a stepwise methodology covering assessment of digital readiness, identification of user requirements, workflow and business process mapping, system design and adaptation, software selection, testing, deployment and scale-up. It emphasizes person-centred care, interoperability, longitudinal health records, decision support and the use of standards-based digital architectures. Through practical tools, worksheets and implementation guidance, the publication supports policy-makers, programme managers, digital health practitioners and software developers in designing and optimizing digital systems that improve service quality, strengthen accountability and enable more effective, integrated and responsive primary health care services."
  },
  {
    "id": "9789240116191-eng",
    "type": "book",
    "title": "Digital transformation handbook for health product catalogue",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2025,
          10,
          30
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/383309",
    "language": "en",
    "abstract": "This handbook provides guidance for the implementation of standardized product master data management through national product catalogues (NPCs) to support digital transformation in health supply chains. Developed within the framework of the WHO Digital Implementation Investment Guide and aligned with the SMART Guidelines initiative, the publication outlines regulatory, governance, technological and operational approaches for establishing interoperable product registries and harmonized product information systems. It explains the importance of standardized product master data for ensuring accurate identification, tracking and management of health products across manufacturers, regulatory authorities, procurement entities, warehouses, health facilities and other supply chain stakeholders.\n\nThe handbook describes policies and procedures for data governance, coding structures, interoperability standards, change management and capacity-building to support sustainable implementation. It also presents guidance on integrating standardized product master data with digital health, regulatory and supply chain systems to improve forecasting, procurement, inventory management, pharmacovigilance, product recalls and traceability. In addition, the publication highlights mechanisms for sharing product master data as a global good and leveraging WHO-hosted tools and open standards to strengthen coordination, data quality and supply chain efficiency across countries and organizations."
  },
  {
    "id": "10665-381036",
    "type": "report",
    "title": "WHO consolidated guidelines on tuberculosis: module 3: diagnosis: web annex B: evidence synthesis and analysis",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2025,
          4,
          10
        ]
      ]
    },
    "publisher": "World Health Organization",
    "DOI": "https://doi.org/10.2471/B09341",
    "URL": "https://iris.who.int/handle/10665/381036",
    "language": "en",
    "abstract": "This web annex to the WHO consolidated guidelines on tuberculosis, Module 3: Diagnosis, compiles the evidence synthesis and analyses used to inform WHO recommendations on diagnostic technologies for tuberculosis and drug-resistant tuberculosis. The publication presents systematic reviews, meta-analyses, qualitative evidence syntheses and economic evaluations examining the diagnostic accuracy, safety, cost–effectiveness and implementation considerations of multiple diagnostic approaches, including low- and moderate-complexity nucleic acid amplification tests, targeted next-generation sequencing technologies and Mycobacterium tuberculosis antigen-based skin tests.\n\nThe annex describes the methods applied to identify, assess and synthesize evidence across diverse populations and settings, including adults, adolescents, children and people living with HIV. It addresses the detection of pulmonary and extrapulmonary tuberculosis, rifampicin resistance and multidrug-resistant tuberculosis using respiratory and non-respiratory specimens. The document also examines stakeholder and user perspectives, operational feasibility and factors influencing implementation. Developed in accordance with WHO guideline development standards, the annex provides the technical evidence base underpinning updates to WHO policy guidance on tuberculosis diagnosis and drug-resistance testing."
  },
  {
    "id": "9789240124233-eng",
    "type": "book",
    "title": "Consolidated HIV guidelines: service delivery",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2026,
          7,
          22
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240124233 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/386765",
    "language": "en",
    "abstract": "HIV remains a major public health challenge, particularly in low- and middle-income countries, despite the availability of effective treatment and prevention tools. Many evidence-based interventions are not implemented consistently or delivered in a timely manner, contributing to ongoing HIV transmission, advanced disease and preventable mortality. These consolidated WHO guidelines provide evidence-based recommendations to strengthen HIV service delivery through people-centred, integrated and equitable approaches that improve access to care, continuity of treatment and accelerate progress towards ending AIDS as a public health threat.\n\nThe publication consolidates all WHO recommendations on HIV service delivery issued between 2013 and 2025. It is intended to support the development of national and subnational policies, clinical guidelines and implementation guidance. It addresses key components of HIV service delivery, including linkage to care and antiretroviral therapy initiation, clinical follow-up and medication refills, adherence support and re-engagement in care, services for adolescents and young people, task sharing, decentralized service delivery, and integration with maternal and child health, tuberculosis, sexual and reproductive health, diabetes, hypertension and mental health services. Recommendations are classified as new, updated or revalidated according to WHO guideline development procedures."
  },
  {
    "id": "9789240120747-eng",
    "type": "book",
    "title": "Digital transformation handbook for reporting substandard and falsified medical products",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2026,
          6,
          9
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240120747 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/386358",
    "language": "en",
    "abstract": "This handbook provides practical guidance to support countries in planning, designing and implementing digital solutions for reporting substandard and falsified medical products. These products pose a significant threat to public health, contributing to therapeutic failure, adverse effects, loss of trust in health systems and broader socioeconomic impacts. Effective detection and reporting are essential to enable regulatory authorities to investigate suspected cases, remove harmful products from circulation and contribute to global surveillance efforts through mechanisms such as WHO’s Global Surveillance and Monitoring System.\n\nThe document outlines a structured approach to digital transformation, covering assessment of the current environment, stakeholder engagement, governance and policy alignment, definition of system requirements, implementation planning, and monitoring and evaluation. It emphasizes the transition from fragmented or paper-based reporting systems to interoperable digital platforms that improve data quality, standardization and timeliness. Drawing on global experience and existing WHO frameworks, the handbook promotes the use of user-centred design, open standards and integration with pharmacovigilance systems. It is intended for ministries of health, national regulatory authorities and partners seeking to strengthen reporting systems and enhance the capacity to detect and respond to substandard and falsified medical products."
  },
  {
    "id": "10665-385385",
    "type": "book",
    "title": "Global hepatitis report 2026",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2026,
          4,
          24
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240122383 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/385385",
    "language": "en",
    "abstract": "This report provides a comprehensive assessment of the global burden of viral hepatitis and progress towards the goal of eliminating hepatitis as a public health threat by 2030. Drawing on data reported by Member States and modelled estimates, it analyses trends in incidence, prevalence and mortality associated with hepatitis B and C, covering the period from 2015 to 2024 based on the latest available data. It also situates these trends within the context of global commitments, strategies and targets.\n\nThe publication reviews the coverage and impact of key interventions for prevention, diagnosis and treatment, including vaccination, infection prevention and control, harm reduction and access to antiviral therapies. It identifies persistent gaps in testing and treatment, marked regional disparities, and the need for accelerated scale-up of services, particularly in high-burden settings. The report concludes that progress towards the 2030 elimination targets remains off track despite the availability of effective interventions. Intended for policymakers, programme managers and public health stakeholders, it serves as an analytical and strategic resource to guide national and global responses to viral hepatitis."
  },
  {
    "id": "9789240122925-eng",
    "type": "book",
    "title": "National health workforce accounts: health workforce levels and trends 2026",
    "author": [
      {
        "literal": "World Health Organization"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2026,
          6,
          22
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "9789240122925 (electronic version)",
    "URL": "https://iris.who.int/handle/10665/386519",
    "language": "en",
    "abstract": "This report presents the 2026 edition of the National Health Workforce Accounts (NHWA) series, providing an overview of the status of NHWA implementation and an analysis of global and regional health workforce levels and trends based on official data reported by countries to the World Health Organization. Developed to support evidence-informed health workforce policy-making and planning, the report examines progress in strengthening national health workforce information systems, data availability and reporting across countries, and the use of standardized indicators to monitor human resources for health in support of universal health coverage, the Sustainable Development Goals and other health objectives.\n\nDrawing on the 2025 NHWA data release, the report analyses the distribution, density and composition of the health and care workforce across regions and income groups, highlighting persistent disparities in workforce availability. It also examines trends in workforce growth since 2006 and presents a thematic analysis of population ageing and health workforce ageing, assessing their implications for future workforce needs. The findings demonstrate substantial improvements in the availability and quality of health workforce data through NHWA implementation while underscoring continuing challenges related to workforce shortages, inequities in distribution and the need for sustained investment in health workforce planning and monitoring."
  },
  {
    "id": "WER9009_69-88",
    "type": "document",
    "title": "Japanese Encephalitis Vaccines : WHO position paper — February 2015 = Note de synthèse : position de l’OMS à propos des vaccins contre l’encéphalite japonaise — février 2015",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          2,
          27
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/242325",
    "language": "en"
  },
  {
    "id": "WER9008_57-62",
    "type": "document",
    "title": "Meningococcal A conjugate vaccine : updated guidance, February 2015 = Vaccin antiméningococcique conjugué contre le sérogroupe A : orientations actualisées, février 2015",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          2,
          20
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/242320",
    "language": "en"
  },
  {
    "id": "WER9234-477-498",
    "type": "document",
    "title": "Cholera vaccines:  WHO position paper –  August 2017 – Vaccins anticholériques: Note de synthèse de l’OMS – août 2017",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          8,
          25
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/258764",
    "language": "en"
  },
  {
    "id": "WER9227-369-392",
    "type": "document",
    "title": "Hepatitis B vaccines: WHO position paper – July 2017 – Vaccins anti-hépatite B: note de synthèse de l’OMS – juillet 2017",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7,
          7
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/255873"
  },
  {
    "id": "WER9217-205-227",
    "type": "document",
    "title": "Measles vaccines: WHO position paper – April 2017 – Note de synthèse de l’OMS sur les vaccins contre la rougeole – avril 2017",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          4,
          28
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/255377",
    "language": "en"
  },
  {
    "id": "WER9206-53-76",
    "type": "document",
    "title": "Tetanus vaccines: WHO position paper – February 2017 = Note de synthèse: position de l’OMS sur les vaccins antitétaniques – février 2017",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          2,
          10
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/254583",
    "language": "en"
  },
  {
    "id": "WER9308-73-96",
    "type": "document",
    "title": "BCG vaccines: WHO position paper – February 2018 – Vaccins BCG: Note de synthèse de l’OMS – Février 2018",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          2,
          23
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/260307",
    "language": "en"
  },
  {
    "id": "WER9335-457-476",
    "type": "document",
    "title": "Dengue vaccine: WHO position paper – September 2018 – Note de synthèse de l’OMS sur le vaccin contre la dengue– septembre 2018",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          9,
          7
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/274316",
    "language": "en"
  },
  {
    "id": "WER9316-201-219",
    "type": "document",
    "title": "Rabies vaccines: WHO position paper – April 2018 – Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          4,
          20
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/272372",
    "language": "en"
  },
  {
    "id": "WER9313-153-172",
    "type": "document",
    "title": "Typhoid vaccines: WHO position paper – March 2018 – Vaccins antityphoïdiques: note de synthèse de l’OMS – mars 2018",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          3,
          30
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/272273",
    "language": "en"
  },
  {
    "id": "WER9408-85-103",
    "type": "document",
    "title": "Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper –February 2019 ─ Vaccins antipneumococciques conjugués chez les nourrissons et les enfants de moins de 5 ans: note de synthèse de l’OMS – février 2019",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          2,
          22
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/310970",
    "language": "zh"
  },
  {
    "id": "WER9527-306-324-eng-fre",
    "type": "document",
    "title": "Rubella vaccines: WHO position paper – July 2020 – Note de synthèse: position de l’OMS concernant les vaccins antirubéoleux",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          7,
          3
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/332952",
    "language": "en"
  },
  {
    "id": "WER9623-217-228-eng-fre",
    "type": "document",
    "title": "Considerations for pneumococcal vaccination in older adults – Considérations relatives à la vaccination antipneumococcique chez les personnes âgées",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          6,
          11
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/341722",
    "language": "en"
  },
  {
    "id": "WER9628-301-319-eng-fre",
    "type": "document",
    "title": "Rotavirus vaccines: WHO position paper – July 2021 – Vaccins antirotavirus : note de synthèse de l’OMS – Juillet 2021",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          16
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/342905",
    "language": "en"
  },
  {
    "id": "WER9750-645-672-eng-fre",
    "type": "document",
    "title": "Human papillomavirus vaccines: WHO position paper (2022 update) –Vaccins contre les papillomavirus humains: note de synthèse de l’OMS (mise à jour de 2022)",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          12,
          16
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/365351",
    "language": "en"
  },
  {
    "id": "WER9709-61-78-eng-fre",
    "type": "document",
    "title": "Malaria vaccine: WHO position paper – March 2022 – Rapport mensuel des cas de dracunculose, janvier 2022",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          3,
          4
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/352337",
    "language": "en"
  },
  {
    "id": "WER9725-277-300-eng-fre",
    "type": "document",
    "title": "Polio vaccines: WHO position paper – June 2022 – Vaccins antipoliomyélitiques: note de synthèse de l’OMS – juin 2022",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          6,
          25
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/357168",
    "language": "en"
  },
  {
    "id": "WER9719-185-208-eng-fre",
    "type": "document",
    "title": "Vaccines against influenza: WHO position paper – May 2022 – Vaccins antigrippaux: note de synthèse de l’OMS – mai 2022",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          5,
          13
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/354265",
    "language": "en"
  },
  {
    "id": "WER9740-493-512-eng-fre",
    "type": "document",
    "title": "WHO position paper on hepatitis A vaccines – October 2022 – Note de synthèse: position de l’OMS concernant les vaccins contre l’hépatite A – Octobre 2022",
    "author": [
      {
        "literal": "World Health Organization = Organisation mondiale de la Santé"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          10,
          7
        ]
      ]
    },
    "publisher": "World Health Organization = Organisation mondiale de la Santé",
    "URL": "https://iris.who.int/handle/10665/363397",
    "language": "en"
  },
  {
    "id": "10665-61960",
    "type": "document",
    "title": "Requirements for rabies vaccine for human use produced in continuous cell lines : requirements for Biological Substances 22 (revised 1986",
    "author": [
      {
        "literal": "World Health Organization. Biologicals Unit"
      },
      {
        "family": "WHO Expert Committee on Biological Standardization (1985  : Geneva",
        "given": "Switzerland)"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1986,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/61960",
    "language": "en"
  },
  {
    "id": "10665-59577",
    "type": "document",
    "title": "Guidelines for the prevention and control of infection with LAV/HTLV III",
    "author": [
      {
        "literal": "World Health Organization. Control Programme on AIDS"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1986,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "URL": "https://iris.who.int/handle/10665/59577",
    "language": "en",
    "abstract": "These guidelines provide recommendations for preventing and controlling infection with LAV/HTLV-III, the retrovirus recognized at the time as the etiological agent of acquired immunodeficiency syndrome (AIDS). Developed as part of the WHO AIDS Control Programme, they are intended primarily for public health authorities and health professionals, who are responsible for adapting the guidance to different populations and settings. The document summarizes available knowledge on transmission, clinical manifestations, laboratory detection, surveillance, notification and confidentiality, and case definitions for AIDS.\n\nThe guidelines emphasize routine precautions to prevent exposure to blood and other potentially infectious body fluids, particularly among health care workers, laboratory personnel and providers of home and emergency care. They address prevention and management of needlestick, parenteral and mucous-membrane exposures, safe handling of specimens and contaminated equipment, and precautions for non-health-care workers. Guidance is also provided on disinfection, sterilization, and the safe processing of reusable needles, syringes and other instruments."
  },
  {
    "id": "10665-107919",
    "type": "report",
    "title": "8th National Tuberculosis Programme Managers Meeting and 13th Wolfheze Workshop: Wolfheze 2008: tuberculosis management, surveillance and evaluation in Europe with high rates or threat of multidrug resistant tuberculosis: The Hague, the Netherlands, 1–2 June 2008",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for Europe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for Europe",
    "URL": "https://iris.who.int/handle/10665/107919",
    "language": "en",
    "abstract": "The WHO European Region has the highest rates in the world of drug-resistant tuberculosis and increasing rates of HIV/tuberculosis coinfection. Eighteen high-priority countries have been identified to urgently scale up tuberculosis control interventions: Armenia, Azerbaijan, Belarus, Bulgaria, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, the Republic of Moldova, Romania, the Russian Federation, Tajikistan, Turkey, Turkmenistan, Ukraine and Uzbekistan. Five of these countries are members of the European Union. Migration and pockets of poverty increase vulnerability to tuberculosis in many western European countries. Related areas, such as the rapid detection of drug-resistant tuberculosis, contact tracing, infection control, health system strengthening and the review of national tuberculosis programmes, are of equal concern among eastern, central and western countries of the WHO European Region. While general awareness and political commitment were raised during the Ministerial Forum held in Berlin in October 2007, how to ensure the follow-up of the Berlin Declaration on TB and monitor its implementation is currently under discussion. The 8th National Tuberculosis Programme Managers Meeting and the 13th Wolfheze Workshop, jointly organized in June 2008 in The Hague, provided a forum for discussion on each of the aforementioned topics and facilitated the sharing of experiences between countries in the Region – which are very different from an epidemiological, organizational, cultural and wealth perspective."
  },
  {
    "id": "10665-351406",
    "type": "report",
    "title": "The case for investing in public health: the strengthening public health services and capacity. A key pillar of the European regional health policy framework Health 2020",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for Europe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for Europe",
    "URL": "https://iris.who.int/handle/10665/351406",
    "language": "en",
    "abstract": "The economic crisis has led to increased demand and reduced resources for health sectors. The trend for increasing healthcare costs to individuals, the health sector and wider society is significant. Public health can be part of the solution to this challenge. The evidence shows that prevention can be cost-effective, provide value for money andgive returns on investment in both the short and longer terms. This public health summary outlines quick returns on investment for health and other sectors for interventions that promote physical activity and healthy employment; address housing and mental health; and reduce road traffic injuries and violence. Vaccinations and screening programmes are largely cost-effective. Population-level approaches are estimated to cost on average five times less than individual interventions. This report gives examples of interventions with early returns on investment and approaches with longer-term gains. Investing in cost-effective interventions to reduce costs to the health sector and other sectors can help create sustainable health systems and economies for the future."
  },
  {
    "id": "10665-346431",
    "type": "report",
    "title": "Measles and rubella elimination country profile: Slovakia",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for Europe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for Europe",
    "URL": "https://iris.who.int/handle/10665/346431",
    "language": "en",
    "abstract": "Conclusions and recommendations of the European Regional Verification Commission for Measles and Rubella Elimination, based on 2017 data submitted by national verification committees."
  },
  {
    "id": "10665-347190",
    "type": "report",
    "title": "Routine immunization profile: Switzerland",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for Europe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for Europe",
    "URL": "https://iris.who.int/handle/10665/347190",
    "language": "en",
    "abstract": "Summary of routine immunization and vaccine-preventable diseases surveillance data, based primarily on data for 2017 submitted through the WHO/UNICEF Joint Reporting Form on Immunization."
  },
  {
    "id": "10665-342490",
    "type": "report",
    "title": "Job aid for COVID-19 vaccine administration: Janssen–Cilag International NV (Belgium) Ad26.COV2.S COVID-19 vaccine (international non-proprietary name: Ad26.COV2.S COVID-19 Vaccine)",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for Europe"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2021,
          7,
          8
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for Europe",
    "URL": "https://iris.who.int/handle/10665/342490",
    "language": "en"
  },
  {
    "id": "10665-205344",
    "type": "book",
    "title": "Information, education and communication: a guide for AIDS programme managers",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for South-East Asia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2000,
          12,
          31
        ]
      ]
    },
    "publisher": "WHO Regional Office for South-East Asia",
    "URL": "https://iris.who.int/handle/10665/205344",
    "language": "en",
    "abstract": "Information, education and communication (IEC) activities can be very effective in bringing about appropriate changes in behaviour, especially among populations with high-risk behaviour. IEC is also important for advocacy to motivate policy and decision-makers to create environments conducive to behavioural change, and to provide much needed services. This guide describes the steps in HIV/AIDS IEC planning and implementation. Although directed primarily to managers of National AIDS control programmes, it is also useful for non-governmental IEC activities."
  },
  {
    "id": "10665-205022",
    "type": "document",
    "title": "Enumeration of CD4 T lymphocytes : report of a workshop, Bangkok, Thailand, 6-10 June 2006",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for South-East Asia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          12,
          31
        ]
      ]
    },
    "publisher": "WHO Regional Office for South-East Asia",
    "URL": "https://iris.who.int/handle/10665/205022",
    "language": "en",
    "abstract": "Description: Enumeration of CD4 T lymphocytes is essential for initiation of antiretroviral therapy for a person with HIV as well as for monitoring the response to treatment. The techniques for enumeration of CD4 T lymphocytes are evolving. The flow cytometry continues to be the gold standard of CD4 T lymphocytes enumeration in spite of the fact that the technology is expensive both in terms of initial investment in sophisticated equipment and running cost. The newer techniques may be economical to procure and maintain. The latter are particularly intended for countries with limited resources. WHO conducted a workshop to orient the nationals about these technologies and integration of a quality system into routine testing, at Siriraj Hospital Bangkok. The report describes the status of CD4 testing in these countries. While Indonesia, India and Thailand have developed a good infrastructure for enumeration of CD4 T lymphocytes, Bangladesh, Myanmar, Nepal and Sri Lanka have made a beginning in this direction. The workshop focussed on principles of various techniques and imparted a hands-on training for performing the same. The issues regarding selection of technology, procurement of equipment and their maintenance; ensuring continuous supply and economical use of reagents and biosafety in laboratory were discussed and have been presented in this Report."
  },
  {
    "id": "b0426",
    "type": "document",
    "title": "National health accounts",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for South-East Asia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          12,
          31
        ]
      ]
    },
    "publisher": "WHO Regional Office for South-East Asia",
    "URL": "https://iris.who.int/handle/10665/205544",
    "language": "en",
    "abstract": "This activity which was initiated as a multi-country activity for countries of the SEA Region, was organized by the WCO India with the technical assistance of SEARO. With the enthusiasm shown by the some of the countries of the WHO Western Pacific Region this activity was concluded as a bi-regional activity. The objective of this workshop was to strengthen the national financial management mechanisms in health. The publication describes the process, technical sessions, countries presentations. Overview of sub-accounts, and how SEARO would propose that NHA agenda is taken forward"
  },
  {
    "id": "10665-365881",
    "type": "book",
    "title": "Two years of work that can transform the health system in a fragile setting: WHO’s response to COVID-19 in Somalia, 2020–2022: road to an inclusive recovery",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for the Eastern Mediterranean"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          12,
          1
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for the Eastern Mediterranean",
    "ISBN": "9789292740610",
    "URL": "https://iris.who.int/handle/10665/365881",
    "language": "en"
  },
  {
    "id": "10665-207050",
    "type": "book",
    "title": "Developing health management information systems : a practical guide for developing countries",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for the Western Pacific"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12,
          31
        ]
      ]
    },
    "publisher": "WHO Regional Office for the Western Pacific",
    "ISBN": "9290611650",
    "URL": "http://iris.wpro.who.int/handle/10665.1/5498",
    "language": "en"
  },
  {
    "id": "wpr-rdo-2020-003-eng",
    "type": "book",
    "title": "Publication and information products style guide",
    "author": [
      {
        "literal": "World Health Organization. Regional Office for the Western Pacific"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          5,
          12
        ]
      ]
    },
    "publisher": "WHO Regional Office for the Western Pacific",
    "URL": "http://iris.wpro.who.int/handle/10665.1/14518",
    "language": "en",
    "abstract": "This is the style guide for WPRO publications and information products. All designers working on WHO WPRO publication and information products should use this as reference for design and layout. Templates and further guidelines are also available. For more information on WPRO publications guidelines, please contact wpropuballstaff@who.int"
  },
  {
    "id": "who-pub-tps-931",
    "type": "book",
    "title": "WHO editorial style manual",
    "author": [
      {
        "literal": "World Health Organization. Technical Publications Unit"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1993,
          12,
          31
        ]
      ]
    },
    "publisher": "World Health Organization",
    "ISBN": "8872660203 (ita)",
    "URL": "https://iris.who.int/handle/10665/36842",
    "language": "en"
  },
  {
    "id": "10665-111245",
    "type": "document",
    "title": "Проект четвертого доклада Комитета А",
    "author": [
      {
        "family": "Всемирная ассамблея здравоохранения",
        "given": "27 сессия"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1974,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/111245",
    "language": "ru"
  },
  {
    "id": "10665-202203",
    "type": "document",
    "title": "Глобальная стратегия предупреждения СПИД и борьбы с ним: проект резолюции, предложенный делегациями Австралии, Бахрейна, Бельгии, Ботсваны, Бурунди, Гаити, Гамбии, Гвинеи, Дании, Заира, Зaмбии, Зимбабве, Индии, Иcландии, Италии,.Камеруна, Канады, Катара, Кении, Кувейта, Лесото, Либерии, Мапави, Мозамбика, Нидерландов, Норвегии, Объединенной Республики Танзании, Свазиленда, Сейшельских Островов, Соединенного Королевства Великобритании и Северной Ирландии, Сомали, Союза Советских Социалистических Республик, Того, Уганды, Финляндии, Франции, Чада, Швейцарии, Швеции и Эфиопии",
    "author": [
      {
        "family": "Всемирная ассамблея здравоохранения",
        "given": "40 сессия"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1987,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/202203",
    "language": "ru"
  },
  {
    "id": "10665-81619",
    "type": "document",
    "title": "Третий доклад Комитета А : (проект)",
    "author": [
      {
        "family": "Всемирная ассамблея здравоохранения",
        "given": "54 сессия"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/81619",
    "language": "ru"
  },
  {
    "id": "10665-253894",
    "type": "document",
    "title": "Картирование риска желтой лихорадки и рекомендованная вакцинация для лиц, совершающих поездки",
    "author": [
      {
        "family": "Всемирная ассамблея здравоохранения",
        "given": "68"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/253894",
    "language": "ru"
  },
  {
    "id": "10665-279508",
    "type": "document",
    "title": "Цифровое здравоохранение",
    "author": [
      {
        "family": "Всемирная ассамблея здравоохранения",
        "given": "71"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/279508",
    "language": "ru"
  },
  {
    "id": "10665-354214",
    "type": "report",
    "title": "Предварительные рекомендации по применению инактивированной вакцины CoronaVac против COVID-19, разработанной Sinovac: Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.)",
    "author": [
      {
        "literal": "Всемирная организация здравоохранения"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          5,
          11
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения. Европейское региональное бюро",
    "URL": "https://iris.who.int/handle/10665/354214",
    "language": "ru"
  },
  {
    "id": "10665-374940",
    "type": "report",
    "title": "Укрепление национальных систем эпиднадзора в отношении элиминации кори и краснухи в Европейском регионе ВОЗ: Бонн, Германия, 8–9 декабря 2011 г.: отчет совещания",
    "author": [
      {
        "literal": "Всемирная организация здравоохранения. Европейское региональное бюро"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения. Европейское региональное бюро",
    "URL": "https://iris.who.int/handle/10665/374940",
    "language": "ru"
  },
  {
    "id": "10665-25966",
    "type": "document",
    "title": "Доклады о ходе работы: доклад Секретариата",
    "author": [
      {
        "family": "Исполнительный комитет",
        "given": "130"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          4,
          25
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/25966",
    "language": "ru"
  },
  {
    "id": "10665-174143",
    "type": "document",
    "title": "Доклад Исследовательской группы по выработке требований, рекомендуемых в отношении вакцины против полиомиэлита",
    "author": [
      {
        "family": "Исполнительный комитет",
        "given": "23 сессия"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1959,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/174143",
    "language": "ru"
  },
  {
    "id": "10665-174300",
    "type": "document",
    "title": "Очередной обзор программ вакцинации БЦЖ",
    "author": [
      {
        "family": "Исполнительный комитет",
        "given": "24 сессия"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1959,
          12,
          31
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения",
    "URL": "https://iris.who.int/handle/10665/174300",
    "language": "ru"
  },
  {
    "id": "10665-192500",
    "type": "document",
    "title": "البرنامج الموسع للتمـنـيع :تقرير مرحلي وتقييمي",
    "author": [
      {
        "family": "جمعية الصحة العالمية",
        "given": "42"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1989,
          12,
          31
        ]
      ]
    },
    "publisher": "منظمة الصحة العالمية",
    "URL": "https://iris.who.int/handle/10665/192500",
    "language": "ar"
  },
  {
    "id": "10665-279510",
    "type": "document",
    "title": "الصحــة الـرقمية",
    "author": [
      {
        "literal": "جمعية الصحة العالمية، ٧١"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "منظمة الصحة العالمية",
    "URL": "https://iris.who.int/handle/10665/279510",
    "language": "ar"
  },
  {
    "id": "10665-379160",
    "type": "book",
    "title": "تصنيف التدخلات والخدمات والتطبيقات الرقمية في مجال الصحة: لغة مشتركة لوصف استخدامات التكنولوجيا الرقمية من أجل الصحة",
    "author": [
      {
        "literal": "منظمة الصحة العالمية"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2024,
          10,
          8
        ]
      ]
    },
    "publisher": "منظمة الصحة العالمية",
    "ISBN": "9789240093768 (نسخة إلكترونية)",
    "URL": "https://iris.who.int/handle/10665/379160",
    "language": "ar",
    "abstract": "تقدم هذه الطبعة الثانية من «تصنيف التدخلات والخدمات والتطبيقات الرقمية في مجال الصحة» تصنيفاً معيارياً يصف كيفية استخدام التقنيات الرقمية لتلبية احتياجات الأفراد والنظم الصحية. وقد أعدت منظمة الصحة العالمية هذا التصنيف ليكون لغة مشتركة تدعم التواصل بين صانعي السياسات، ومديري البرامج الصحية، والباحثين، والمنفذين، ومطوري التكنولوجيا، وغيرهم من أصحاب المصلحة في مجال الصحة الرقمية. وينظم التصنيف التدخلات الصحية الرقمية حول قدرات تكنولوجية محددة صُممت لمعالجة التحديات التي تواجه النظم الصحية، ويربط هذه التدخلات بالخدمات وأنواع التطبيقات الرقمية التي تُستخدم لتنفيذها.\n\nويُحدِّث هذا المنشور ويوسِّع الطبعة الأولى الصادرة عام 2018 ليعكس التقدم في تقنيات الصحة الرقمية، وتطور ممارسات التنفيذ، والدروس المستفادة من استخدامها على المستوى العالمي. ويستند الإطار إلى ثلاثة محاور مترابطة: تحديات النظم الصحية، والتدخلات الصحية الرقمية، والخدمات وأنواع التطبيقات الرقمية. ويشمل تدخلات موجهة للأفراد، ولمقدمي الرعاية الصحية، ولمديري النظم الصحية، ولخدمات البيانات، إلى جانب فئات التطبيقات الرقمية ونظم المعلومات. ويهدف هذا التصنيف إلى دعم التخطيط والتنفيذ، وتحليل الاستثمارات، والبحوث، واعتبارات التشغيل البيني، وصياغة السياسات، وحوكمة مبادرات الصحة الرقمية، بما يعزز الاستخدام المنسق والفعال للتقنيات الرقمية في النظم الصحية."
  },
  {
    "id": "10665-83077",
    "type": "document",
    "title": "甲委员会第一份报告：（草案）",
    "author": [
      {
        "family": "世界卫生大会",
        "given": "53"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2000,
          12,
          31
        ]
      ]
    },
    "publisher": "世界卫生组织",
    "URL": "https://iris.who.int/handle/10665/83077",
    "language": "zh"
  },
  {
    "id": "10665-195658",
    "type": "document",
    "title": "卫生组织防治获得性免疫缺损综合症的活动",
    "author": [
      {
        "literal": "执行委员会，77"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1986,
          12,
          31
        ]
      ]
    },
    "publisher": "世界卫生组织",
    "URL": "https://iris.who.int/handle/10665/195658",
    "language": "zh"
  },
  {
    "id": "10665-198389",
    "type": "document",
    "title": "区域主任关于区域关键性业务和管理改革问题战略和进展的报告：非洲区域主任的报告",
    "author": [
      {
        "literal": "执行委员会，95"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1994,
          12,
          31
        ]
      ]
    },
    "publisher": "世界卫生组织",
    "URL": "https://iris.who.int/handle/10665/198389",
    "language": "zh"
  },
  {
    "id": "10665-279509",
    "type": "document",
    "title": "数字卫生保健",
    "author": [
      {
        "literal": "第七十一届世界卫生大会"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          31
        ]
      ]
    },
    "publisher": "世界卫生组织",
    "URL": "https://iris.who.int/handle/10665/279509",
    "language": "zh"
  }
]
